UiPath (PATH) 10-K 27 Mar 24 2024 FY Annual report Financial data

Cover

Cover - USD ($) $ in Billions	12 Months Ended
	Jan. 31, 2024	Mar. 21, 2024	Jul. 31, 2023
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jan. 31, 2024
Current Fiscal Year End Date	--01-31
Document Transition Report	false
Entity File Number	001-40348
Entity Registrant Name	UiPath, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4333187
Entity Address, Address Line One	One Vanderbilt Avenue, 60th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	844
Local Phone Number	432-0455
Title of 12(b) Security	Class A common stock, par value$0.00001 per share
Trading Symbol	PATH
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction	false
Entity Shell Company	false
Entity Public Float			$ 7.4
Documents Incorporated by Reference	Part III of this Annual Report on Form 10-K incorporates by reference certain information that will be set forth in the registrant's Proxy Statement in connection with the 2024 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission within 120 days of January 31, 2024. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.
Amendment Flag	false
Entity Central Index Key	0001734722
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		486,559,509
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		82,452,748

Audit Information

Audit Information	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2022
Audit Information [Abstract]
Auditor Firm ID	185	248
Auditor Name	KPMG LLP	GRANT THORNTON LLP
Auditor Location	New York, New York	New York, New York

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 1,061,678	$ 1,402,119
Restricted cash	438	0
Marketable securities	818,145	354,774
Accounts receivable, net of allowance for credit losses of $1,119 and $2,698, respectively	436,296	374,217
Contract assets	84,197	69,260
Deferred contract acquisition costs	74,678	49,887
Prepaid expenses and other current assets	104,980	94,150
Total current assets	2,580,412	2,344,407
Marketable securities, non-current	0	2,942
Contract assets, non-current	6,214	6,523
Deferred contract acquisition costs, non-current	154,317	137,616
Property and equipment, net	23,982	29,045
Operating lease right-of-use assets	56,072	52,052
Intangible assets, net	14,704	23,010
Goodwill	89,026	88,010
Deferred tax assets	4,678	5,895
Other assets, non-current	25,353	45,706
Total assets	2,954,758	2,735,206
Current liabilities
Accounts payable	3,447	8,891
Accrued expenses and other current liabilities	83,997	76,645
Accrued compensation and employee benefits	137,442	142,582
Deferred revenue	486,805	398,334
Total current liabilities	711,691	626,452
Deferred revenue, non-current	161,027	121,697
Operating lease liabilities, non-current	58,713	56,442
Other liabilities, non-current	7,213	10,457
Total liabilities	938,644	815,048
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	0	0
Treasury stock, at cost, 5,840 shares and none, respectively	(102,615)	0
Additional paid-in capital	4,024,079	3,736,838
Accumulated other comprehensive income	8,825	7,612
Accumulated deficit	(1,914,181)	(1,824,298)
Total stockholders’ equity	2,016,114	1,920,158
Total liabilities and stockholders’ equity	2,954,758	2,735,206
Class A Common Stock
Stockholders’ equity:
Common stock	5	5
Class B Common Stock
Stockholders’ equity:
Common stock	$ 1	$ 1

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Accounts receivable, allowance for doubtful accounts	$ 1,119	$ 2,698
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	5,840	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000	2,000,000
Common stock, shares issued (in shares)	492,660	474,160
Common stock, shares outstanding (in shares)	486,820	474,160
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	115,741	115,741
Common stock, shares issued (in shares)	82,453	82,453
Common stock, shares outstanding (in shares)	82,453	82,453

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Revenue:
Total revenue	$ 1,308,072	$ 1,058,581	$ 892,252
Cost of revenue:
Total cost of revenue	195,924	180,051	168,868
Gross profit	1,112,148	878,530	723,384
Operating expenses:
Sales and marketing	713,130	701,558	697,682
Research and development	332,101	285,750	276,657
General and administrative	231,637	239,505	249,991
Total operating expenses	1,276,868	1,226,813	1,224,330
Operating loss	(164,720)	(348,283)	(500,946)
Interest income	57,130	27,955	3,551
Other income (expense), net	31,775	2,767	(13,488)
Loss before income taxes	(75,815)	(317,561)	(510,883)
Provision for income taxes	14,068	10,791	14,703
Net loss	$ (89,883)	$ (328,352)	$ (525,586)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.16)	$ (0.60)	$ (1.16)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.16)	$ (0.60)	$ (1.16)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	563,855	548,022	454,625
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	563,855	548,022	454,625
Licenses
Revenue:
Total revenue	$ 621,392	$ 497,836	$ 481,427
Cost of revenue:
Total cost of revenue	10,469	10,421	11,888
Subscription services
Revenue:
Total revenue	649,918	508,823	369,867
Cost of revenue:
Total cost of revenue	111,922	87,366	60,565
Professional services and other
Revenue:
Total revenue	36,762	51,922	40,958
Cost of revenue:
Total cost of revenue	$ 73,533	$ 82,264	$ 96,415

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (89,883)	$ (328,352)	$ (525,586)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale marketable securities, net	519	(284)	(318)
Foreign currency translation adjustments	694	(3,003)	23,738
Other comprehensive income (loss), net	1,213	(3,287)	23,420
Comprehensive loss	$ (88,670)	$ (331,639)	$ (502,166)

Consolidated Statements of Conv

Consolidated Statements of Convertible Preferred Stock and Stockholders Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Treasury stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Accumulated deficit
Beginning Balance (in shares) at Jan. 31, 2021	294,257
Beginning Balance at Jan. 31, 2021	$ 1,221,968
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net of issuance costs (in shares)	12,043
Issuance of convertible preferred stock, net of issuance costs	$ 749,836
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)	(306,300)
Conversion of convertible preferred stock to common stock upon initial public offering	$ (1,971,804)
Ending Balance (in shares) at Jan. 31, 2022	0
Ending Balance at Jan. 31, 2022	$ 0
Beginning Balance (in shares) at Jan. 31, 2021				75,177	110,653
Beginning balance at Jan. 31, 2021	(803,704)			$ 1	$ 1		$ 179,175	$ (12,521)	$ (970,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)				306,300
Conversion of convertible preferred stock to common stock upon initial public offering	1,971,804			$ 3			1,971,801
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs (in shares)				13,000
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs	687,903						687,903
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)				28,200	28,200
Shares issued in connection with business acquisition (in shares)				543
Shares issued in connection with business acquisition	30,467						30,467
Issuance of common stock upon exercise of stock options (in shares)				10,048
Issuance of common stock upon exercise of stock options	12,345						12,345
Vesting of early exercised stock options	3,017						3,017
Issuance of common stock under the employee stock purchase plan (in shares)				411
Issuance of common stock under the employee stock purchase plan	14,462						14,462
Issuance of common stock upon settlement of restricted stock units (in shares)				25,280
Tax withholdings on settlement of restricted stock units (in shares)				(186)
Tax withholdings on settlement of restricted stock units	(10,591)						(10,591)
Stock-based compensation	518,380						518,380
Other comprehensive income (loss), net of tax	23,420							23,420
Net loss	(525,586)	$ (423,296)	$ (102,290)						(525,586)
Ending Balance (in shares) at Jan. 31, 2022				458,773	82,453
Ending balance at Jan. 31, 2022	1,921,917			$ 4	$ 1		3,406,959	10,899	(1,495,946)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in connection with business acquisition (in shares)				570
Shares issued in connection with business acquisition	2,965						2,965
Issuance of common stock upon exercise of stock options (in shares)				4,770
Issuance of common stock upon exercise of stock options	8,245						8,245
Vesting of early exercised stock options	1,357						1,357
Issuance of common stock under the employee stock purchase plan (in shares)				1,190
Issuance of common stock under the employee stock purchase plan	15,804						15,804
Issuance of common stock upon settlement of restricted stock units (in shares)				13,644
Issuance of common stock upon settlement of restricted stock units	1			$ 1
Tax withholdings on settlement of restricted stock units (in shares)				(4,646)
Tax withholdings on settlement of restricted stock units	(75,181)						(75,181)
Charitable donation of Class A common stock (in shares)				300
Charitable donation of Class A common stock	5,499						5,499
Repurchase of unvested early exercised stock options (in shares)				(441)
Stock-based compensation	371,190						371,190
Other comprehensive income (loss), net of tax	(3,287)							(3,287)
Net loss	(328,352)	$ (278,950)	$ (49,402)						(328,352)
Ending Balance (in shares) at Jan. 31, 2023		474,160	82,453	474,160	82,453	0
Ending balance at Jan. 31, 2023	$ 1,920,158			$ 5	$ 1	$ 0	3,736,838	7,612	(1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	5,221			5,221
Issuance of common stock upon exercise of stock options	$ 6,728						6,728
Vesting of early exercised stock options	2						2
Issuance of common stock under the employee stock purchase plan (in shares)				1,364
Issuance of common stock under the employee stock purchase plan	17,313						17,313
Issuance of common stock upon settlement of restricted stock units (in shares)				17,695
Issuance of common stock upon settlement of restricted stock units				$ 0
Tax withholdings on settlement of restricted stock units (in shares)				(6,061)
Tax withholdings on settlement of restricted stock units	(113,162)						(113,162)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	4,215						4,215
Repurchase of Class A common stock (in shares)				(5,800)		(5,840)
Repurchase of Class A common stock	(102,615)					$ (102,615)
Stock-based compensation	372,145						372,145
Other comprehensive income (loss), net of tax	1,213							1,213
Net loss	(89,883)	$ (76,739)	$ (13,144)						(89,883)
Ending Balance (in shares) at Jan. 31, 2024		492,660	82,453	492,660	82,453	(5,840)
Ending balance at Jan. 31, 2024	$ 2,016,114			$ 5	$ 1	$ (102,615)	$ 4,024,079	$ 8,825	$ (1,914,181)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Cash flows from operating activities:
Net loss	$ (89,883)	$ (328,352)	$ (525,586)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	22,597	18,723	14,705
Amortization of deferred contract acquisition costs	75,471	59,826	39,257
Net amortization on marketable securities	(28,246)	(1,782)	1,954
Stock-based compensation expense	371,955	369,840	515,583
Charitable donation of Class A common stock	4,215	5,499	0
Non-cash operating lease expense	13,047	11,675	8,875
Abandonment and impairment charges	0	2,881	0
Provision for deferred income taxes	554	861	(5,832)
Other non-cash (credits) charges, net	(3,700)	(2,465)	1,983
Changes in operating assets and liabilities:
Accounts receivable	(64,217)	(123,783)	(86,387)
Contract assets	(14,694)	(185)	(43,660)
Deferred contract acquisition costs	(118,833)	(118,909)	(130,186)
Prepaid expenses and other assets	4,222	(59,810)	(15,360)
Accounts payable	(5,052)	(1,571)	3,507
Accrued expenses and other liabilities	11,804	(14,954)	45,729
Accrued compensation and employee benefits	(4,039)	15,086	24,038
Operating lease liabilities, net	(13,590)	(3,307)	(9,064)
Deferred revenue	137,471	160,746	105,481
Net cash provided by (used in) operating activities	299,082	(9,981)	(54,963)
Cash flows from investing activities:
Purchases of marketable securities	(1,485,965)	(388,409)	(212,512)
Sales of marketable securities	0	0	89,383
Maturities of marketable securities	1,050,984	151,426	107,745
Purchases of property and equipment	(7,342)	(23,815)	(8,879)
Payments related to business acquisitions, net of cash acquired	0	(29,542)	(5,498)
Capitalized software development costs	0	0	(2,950)
Other investing, net	2,754	1,197	(2,731)
Net cash used in investing activities	(439,569)	(289,143)	(35,442)
Cash flows from financing activities:
Repurchases of Class A common stock	(102,615)	0	0
Proceeds from exercise of stock options	6,740	8,388	12,197
Payments of tax withholdings on net settlement of equity awards	(112,067)	(73,095)	(10,467)
Net (payments) receipts of tax withholdings on sell-to-cover equity award transactions	(645)	(9,480)	10,432
Proceeds from employee stock purchase plan contributions	17,555	15,011	19,040
Payment of deferred consideration related to business acquisition	(5,863)	0	0
Repurchase of unvested early exercised stock options	0	(1,493)	0
Proceeds from initial public offering, net of underwriting discounts and commissions	0	0	692,369
Payments of initial public offering costs	0	0	(3,734)
Proceeds from issuance of convertible preferred stock	0	0	750,000
Issuance costs related to convertible preferred stock	0	0	(164)
Net cash (used in) provided by financing activities	(196,895)	(60,669)	1,469,673
Effect of exchange rate changes	(2,621)	(6,811)	18,265
Net (decrease) increase in cash, cash equivalents, and restricted cash	(340,003)	(366,604)	1,397,533
Cash, cash equivalents, and restricted cash at beginning of period	1,402,119	1,768,723	371,190
Cash, cash equivalents, and restricted cash at end of period	1,062,116	1,402,119	1,768,723
Supplemental disclosures of cash flow information:
Cash paid for interest	563	651	691
Cash paid for income taxes	10,822	20,999	8,454
Supplemental disclosures of non-cash investing and financing activity:
Stock-based compensation capitalized for software development	0	0	4,487
Value of shares issued in payment of business acquisitions	0	2,965	30,467
Loan notes issued in connection with business acquisitions	0	11,433	0
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options	2	1,357	3,017
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	3,354	2,213	270
Purchases of property and equipment included in accounts payable	$ 511	$ 1,056	$ 1,863

Organization and Description of

Organization and Description of Business	12 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1 Organization and Description of Business UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale. We have legal prese nce in 32 countries, with our principal operations in t he U.S., R omania, and Japan.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jan. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2 Summary of Significant Accounting Policies Basis of Presentation The consolidated financial statements have been prepared in accordance with U.S. GAAP and include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. Fiscal Year Our fiscal year ends on January 31. References to fiscal years 2024, 2023, and 2022 refer to the fiscal years ended January 31, 2024, 2023, and 2022, respectively. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease ROU assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense including determination of fair value of common stock prior to our IPO, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions. Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using the average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the consolidated statements of operations. For fiscal years 2024, 2023 and 2022, we recognized foreign currency transaction gains (losses) of $0.3 million, $(0.5) million, and $(17.2) million, respectively, excluding the impact of foreign currency forward contracts (discussed below) in fiscal year 2022. Derivative Financial Instruments From time to time, we use derivative financial instruments, such as foreign currency forward contracts, to manage foreign currency exposures. We account for our derivative instruments as either assets or liabilities and carry them at fair value. These foreign currency contracts are not designated and do not qualify as hedging instruments, as defined by ASC 815, Derivatives and Hedging . Our most recent foreign currency forward contract was terminated on January 28, 2022. We recorded changes in its fair value as a component of other income (expense), net in the consolidated statements of operations. Net gain associated with the foreign currency forward contract was $8.3 million for fiscal year 2022. We did not have foreign currency forward contracts during fiscal year 2023 or 2024. Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where deposits, at times, exceed FDIC limits. As of January 31, 2024 and 2023, 91% and 98%, respectively, of our cash and cash equivalents were concentrated in the U.S., EU countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints. With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For fiscal years 2024, 2023, and 2022, no single customer accounted for 10% or more of our total revenue. As of January 31, 2024 and 2023, no single customer accounted for 10% or more of our accounts receivable. Fair Value of Financial Instruments We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. We determine fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: Level 1—Quoted prices in active markets for identical assets or liabilities that we can access at the measurement date. Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, such as: • quoted prices for similar assets or liabilities in active markets; • quoted prices for identical or similar assets or liabilities in markets that are not active; or • inputs other than quoted prices that are observable or can be corroborated by observable market data. Level 2 inputs must be observable for substantially the full term of the asset or liability. Level 3—Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair value. Financial instruments consist of cash equivalents, marketable securities, accounts receivable, and accounts payable. Marketable securities are recorded at fair value. Cash equivalents, accounts receivable and accounts payable are recorded at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Cash and Cash Equivalents We consider all highly liquid investments purchased with original maturity dates of three months or less to be cash equivalents. Marketable Securities Our marketable securities consist of corporate bonds, municipal bonds, agency bonds, treasury bills and U.S. government securities, and commercial paper with original maturity dates of more than three months from the date of purchase. We determine the appropriate classification of our marketable securities at the time of purchase and reevaluate such designation at each balance sheet date. We have classified and accounted for our marketable securities as available-for-sale securities based on our intentions with regard to these instruments, and we classify them as current or non-current assets in the consolidated balance sheets based on their stated maturity dates. The fair value of available-for-sale marketable securities is remeasured each reporting period. Any premiums and discounts are amortized or accreted over the life of the related available-for-sale security as an adjustment to yield. Interest income is recognized when earned. Unrealized gains and losses on marketable securities are reported as a separate component of accumulated other comprehensive income on the consolidated balance sheets until realized. We evaluate an available-for-sale debt security for impairment if the estimated fair value is below its amortized cost basis. We consider our intent to sell the security or whether it is more likely than not that we will be required to sell the security before recovery of its amortized basis. If either of these conditions exist, the debt security’s amortized cost basis is written down to fair value, with the change recognized in other income (expense), net in the consolidated statements of operations. If neither of these conditions are present, we evaluate whether unrealized losses have resulted from a credit loss or other factors. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry. Credit-related unrealized losses are recognized as an allowance on the consolidated balance sheets with a corresponding charge to other income (expense), net in the consolidated statements of operations. As of January 31, 2024 and 2023 we did not record any allowance for credit losses related to our available-for-sale marketable securities, and we did not record any impairments related to these securities in fiscal years 2024, 2023, or 2022. Accounts Receivable and Allowance for Credit Losses Accounts receivable consist of amounts billed and currently due from customers, which are subject to collection risk. Our accounts receivable are reduced by an allowance for credit losses. This allowance contemplates estimated losses resulting from the inability of our customers to make required payments. It is an estimate and is regularly evaluated for adequacy by taking into consideration a combination of factors such as historical write-off experience, credit quality of the customer, age of the receivable balance, current economic conditions and forecasts of future economic conditions, and projections of future collections. We write off accounts receivable when they are determined to be uncollectible. The allowance for credit losses was $1.1 million and $2.7 million as of January 31, 2024 and 2023, respectively. Credit loss (recovery) expense was $(1.6) million, $1.2 million, and $0.7 million for fiscal years 2024, 2023, and 2022, respectively. Property and Equipment, Net Property and equipment are recorded at historical cost, less accumulated depreciation. Property and equipment are depreciated on a straight-line basis over the estimated useful lives of the assets. Useful lives by asset category are as follows: Asset Category Estimated Useful Life Computer and equipment 1 to 2 years Furniture and fixtures 2 to 9 years Leasehold improvements Shorter of remaining lease term or estimated useful life (1 to 14 years) Internal-Use Software Pursuant to ASC 350-40, Internal Use Software , we capitalize costs incurred to implement cloud computing arrangements that are service contracts and costs incurred to develop internal-use software, which has historically included our SaaS products. ASC 350-40 prescribes capitalization of costs incurred during the application development stage, costs incurred to develop or obtain software that allows for access to or conversion of old data by new systems, and costs incurred in connection with upgrades and enhancements to internal-use software if it is probable that such expenditures will result in additional functionality. These capitalized costs exclude training costs, project management costs, and data migration costs. We evaluate our long-lived assets, including these capitalized costs, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable. Beginning in the fourth quarter of fiscal year 2022, we began to broadly market on-premises versions of certain of our SaaS products, thereby establishing a pattern of marketing internal-use software and a rebuttable presumption that we intend to market any SaaS products we develop. As a result, our ongoing and future SaaS projects must be accounted for under ASC 985-20, Costs of Software to be Sold, Leased or Marketed, which is discussed below under "Software Development Costs." Costs previously capitalized under ASC 350-40 in connection with development of our SaaS products are amortized on a straight-line basis over the product’s estimated useful life of five years and are included in cost of subscription services revenue on the consolidated statements of operations. Capitalized costs include salaries, benefits, and stock-based compensation charges for employees that are directly involved in developing our SaaS products. These capitalized costs are included in other assets, non-current on the consolidated balance sheets. Gross capitalized internal-use software development costs were $7.5 million as of January 31, 2024 and 2023. Amortization expense was $1.3 million, $1.3 million, and $1.2 million for fiscal years 2024, 2023, and 2022, respectively. Accumulated amortization was $4.3 million and $3.0 million as of January 31, 2024 and 2023, respectively. Capitalized costs related to the implementation of cloud computing arrangements that are service contracts are amortized on a straight-line basis over the terms of the associated hosting arrangements and are recorded under operating expenses in the same line item on the consolidated statements of operations as the associated hosting arrangement fees. These gross capitalized costs were $2.7 million and $2.2 million as of January 31, 2024 and 2023, respectively, and are recorded in other assets, non-current on our consolidated balance sheets. Related amortization expense was none, $1.0 million, and $0.9 million for fiscal years 2024, 2023, and 2022, respectively. Accumulated amortization was $2.2 million as of January 31, 2024 and 2023. Software Development Costs We account for costs incurred to develop software to be licensed in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed . These costs include internal development costs and license fees paid to third parties for their software that is integrated into our products. Beginning in the fourth quarter of fiscal year 2022, we also account for costs incurred to develop our SaaS products in accordance with ASC 985-20. This guidance requires that all costs to establish technological feasibility be expensed as they are incurred. Technological feasibility is established when the working model is complete. Costs incurred subsequent to establishing technological feasibility are capitalized until the product is available for general release to customers, at which point they are amortized on a product-by-product basis. Management evaluates the useful life of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact their recoverability. Our internal development costs are amortized over the estimated useful life of the software, which is five years, on a straight-line basis, and are included in cost of licenses revenue or cost of subscription services revenue in the consolidated statements of operations based on the nature of the underlying product. Capitalized costs include salaries, benefits, and stock-based compensation charges for employees that are directly involved in developing our products. Capitalized costs are included in other assets, non-current on the consolidated balance sheets. Gross capitalized software development costs were $4.2 million and $4.3 million as of January 31, 2024 and 2023, respectively. Related amortization expense was $0.9 million, $0.9 million, and $0.7 million for fiscal years 2024, 2023 and 2022, respectively. Accumulated amortization was $3.0 million and $2.1 million as of January 31, 2024 and 2023, respectively. Capitalized license fees paid to third parties are amortized over the license term at the greater of a straight-line or a consumption basis and are included in cost of licenses revenue or cost of subscription services revenue in the consolidated statements of operations based on the nature of the underlying third-party product. Capitalized costs are included in prepaid expenses and other current assets and other assets, non-current on the consolidated balance sheets. Gross capitalized license fees were $4.2 million and $22.4 million as of January 31, 2024 and 2023, respectively. Related amortization expense was $8.4 million, $7.3 million, and $7.5 million for fiscal years 2024, 2023, and 2022, respectively. Accumulated amortization was none and $17.6 million as of January 31, 2024 and 2023, respectively. Leases We determine if an arrangement contains a lease at inception based on whether there is an identified asset and whether we control the use of the identified asset throughout the period of use. We classify leases as either financing or operating leases. We do not have any financing leases. Operating lease liabilities represent our obligation to make payments arising from a lease. Operating lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. The present value of lease payments is discounted based on our incremental borrowing rate unless the rate implicit in the lease is readily determinable, which generally is not the case. We estimate our incremental borrowing rate based on information available at the lease commencement date for collateralized borrowings with a similar term, amount, borrower creditworthiness, and economic environment. Operating lease ROU assets represent our right to use an underlying asset for the lease term. Our operating lease ROU assets are measured based on the corresponding operating lease liability adjusted for (1) payments made to the lessor at or before the commencement date, (2) initial direct costs incurred, and (3) tenant incentives under the lease. Options to renew or terminate the lease are recognized as part of our operating lease ROU assets and operating lease liabilities when it is reasonably certain the options will be exercised. We have elected to not separate lease and non-lease components for any leases within our existing classes of assets. Operating lease expense for fixed lease payments is recognized on a straight-line basis over the lease term. Variable lease payments for real estate taxes, insurance, maintenance, and utilities, which are generally based on our pro-rata share of the total property, are expensed as incurred and are not included in the measurement of the operating lease ROU assets or operating lease liabilities. In addition, we do not recognize ROU assets and lease liabilities for short-term leases which have a lease term of 12 months or less and do not include an option to purchase the underlying asset that we are reasonably certain to exercise. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. Business Acquisitions Assets acquired and liabilities assumed in a business combination are recorded at their respective fair values at the date of the acquisition in accordance with ASC 805, Business Combinations (with the exception of contract assets and contract liabilities, which are measured according to ASC 606, Revenue from Contracts with Customers, discussed under "Revenue Recognition," below). Determination of the fair value of assets acquired and liabilities assumed relies on management judgments and often involves the use of estimates and assumptions, including but not limited to assumptions about future cash inflows and outflows, discount rates, and lives of intangible and other assets. Any excess of the purchase price over the fair value of the net assets acquired is recognized as goodwill. During the one-year measurement period following an acquisition, we may record adjustments to the fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, subsequent adjustments, if any, are recorded in our consolidated statements of operations. Acquisition costs, such as legal and consulting fees, are expensed as incurred. Goodwill and Acquired Intangible Assets Goodwill represents the excess of the purchase price in a business acquisition over the fair value of the net assets acquired and is not amortized. We test goodwill for impairment at the reporting unit level at least annually in November and may test more frequently when events or changes in circumstances indicate that the carrying value may not be recoverable. At the time of testing, if we determine that it is more likely than not that the estimated fair value of our single reporting unit is less than its carrying value, a quantitative assessment is performed by comparing the fair value of the reporting unit with its carrying value. In order to make this determination, we may make an initial assessment of qualitative factors, or may proceed directly to the quantitative impairment test. There were no impairment charges to goodwill during fiscal years 2024, 2023, and 2022. Acquired intangible assets consist primarily of developed technology and customer relationships resulting from our business acquisitions. Intangible assets are recorded at fair value on the date of acquisition and are amortized over their estimated useful lives. Impairment of Long-Lived Assets We evaluate our long-lived assets for indicators of possible impairment when events or changes in circumstances suggest that the carrying amount of an asset or asset group may not be recoverable. We assess recoverability by comparing the carrying amount of such asset or asset group to the net undiscounted future cash flows we expect the asset or asset group to generate. If the carrying amount of an asset or asset group exceeds the related undiscounted cash flows, it is considered to be impaired and an impairment charge is recognized for the amount by which the carrying value of the asset or asset group exceeds its fair value. There were no events or changes in circumstances during fiscal years 2024, 2023, or 2022 which indicated potential impairment of our long-lived assets. Revenue Recognition We derive revenue from the sale of: (1) software licenses for on-premise use of our proprietary software and related maintenance and support; (2) the right to access certain software products we host (i.e., SaaS); and (3) professional services. For many of our products that are available both on-premise and via SaaS, we sell a single offering that allows customers the choice of either on-premise or SaaS deployment throughout the term of the contract. These Flex Offerings are comprised of three types of performance obligations: term license, maintenance and support, and SaaS. In accordance with ASC 606, Revenue from Contracts with Customers , revenue is recognized when or as a customer obtains control of the distinct promised goods and services. The amount of revenue recognized reflects the consideration to which we expect to be entitled in exchange for those goods or services. To achieve the core principle of ASC 606, we apply the following five steps: 1. Identification of the contract, or contracts, with the customer; 2. Identification of the performance obligations in the contract; 3. Determination of the transaction price; 4. Allocation of the transaction price to the performance obligations in the contract; and 5. Recognition of the revenue when, or as, a performance obligation is satisfied. Our significant performance obligations and our application of ASC 606 to each of those performance obligations are discussed in further detail below. Payment terms and conditions vary by contract type, although terms generally require payment within 30 to 60 days of the invoice date. In certain arrangements, we receive payment from a customer either before or after the performance obligation has been satisfied; however, our contracts do not contain a significant financing component. The primary purpose of our invoicing terms is to provide customers with simplified and predictable ways of purchasing our products and services, not to receive financing from our customers or to provide customers with financing. We apply the practical expedient in ASC 606 and do not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recorded net of sales tax. We generally do not offer a right of refund in our contracts. Licenses Our term licenses (typically sold as a portion of Flex Offerings), provide customers the right to use software for a specified period of time. Revenue for licenses is recognized at the point in time at which the customer is able to use and benefit from the software, which is generally upon delivery to the customer or upon commencement of the renewal term. For licenses revenue, we generally invoice when the license(s) are provided or annually at contract anniversary. Subscription Services We generate subscription services revenue through the provision of: (1) maintenance and support, which include technical support and unspecified updates and upgrades on a when-and-if-available basis for our licenses, and (2) SaaS products (typically sold as a portion of Flex Offerings). Maintenance and support represent stand-ready obligations for which revenue is recognized ratably over the term of the arrangements. For maintenance and support, we generally invoice when the associated license(s) are provided or annually at contract anniversary. Customers do not have the contractual right to take possession of the software underlying our SaaS products. Therefore, SaaS products are stand-ready obligations to provide access to our products, and the related revenue is recognized ratably over the contractual term of the arrangement, as control of the services is transferred to the customer. We generally invoice for our SaaS products when the customer is provided access and may begin using the SaaS products or annually at contract anniversary. Professional Services and Other Professional services and other revenue consists of fees associated with professional services for process automation, customer education, and training services. Our professional services contracts are structured on a time and materials or fixed price basis, and the related revenue is recognized as the services are rendered. We use a cost-based input method as the measure of progress toward satisfying the performance obligation. For professional services, we invoice as the services are provided or in advance. Contracts with Multiple Performance Obligations Most of our contracts with customers contain multiple performance obligations. The transaction price is allocated to the separate performance obligations on a relative SSP basis. Whenever possible, we allocate the transaction price based on observable SSP, which is the price of the same good or service in standalone sales to similar customers in similar circumstances. If observable SSP is not available, we estimate the SSP using data that may include historical prices, discounting practices, list prices, cost data, and other observable inputs. Our SSP reflects the amount we would charge for each performance obligation if it were sold separately in standalone sales to similar customers in similar circumstances in similar geographies. Consideration Payable to Customers From time to time, we enter into arrangements wherein we sell our products and services to a customer or partner while also making commitments to purchase products or services from that customer or partner or make investments to enable that customer or partner to create or enhance their automation practice. These commitments are treated as consideration payable to a customer, and therefore as a reduction to the transaction price, when it is determined that the payment is not in exchange for a distinct good or service that is priced at fair market value. If the consideration payable includes a variable amount, we estimate the transaction price, including assessing whether the estimate of variable consideration must be constrained. We also offer certain rebate incentives to our partners which are treated as consideration payable to a customer and therefore accounted for as a reduction to the transaction price of the related revenue arrangements. Modifications We frequently modify contracts to offer customers additional products or services. The additional products and services are generally determined to be distinct from those products or services transferred to the customer before the modification. We evaluate whether the price for the additional products and services reflects the SSP in order to determine the appropriate modification model to apply. If the price reflects SSP, the purchase of additional products and services is accounted for as a separate contract. If the price does not reflect SSP, we account for the modification as the termination of the existing contract and the creation of a new contract. Contract Balances Contract assets consist of unbilled accounts receivable related to goods or services that have been transferred to customers but whose payment is contingent upon future performance. Contract liabilities consist of deferred revenue. Revenue is deferred when we invoice in advance of performance under a contract. Often, certain performance obligations under a contract will be in a contract asset position while other performance obligations under the same contract are in a contract liability position. Contract assets and liabilities pertaining to the same contract are netted in the consolidated balance sheets. Deferred Contract Acquisition Costs We defer sales commissions that are incremental to the acquisition of customer contracts. These costs are recorded as deferred contract acquisition costs on the consolidated balance sheets. We determine whether costs should be deferred based on the terms of our sales compensation and partner incentive plans and whether the commissions are incremental to a customer contract (i.e. would not have occurred absent the customer contract). Under our current sales compensation and certain of our partner incentive plans, commissions for renewals of subscription contracts are not commensurate with the commissions paid on the initial contract. We allocate deferred contract acquisition costs to performance obligations in proportion to the transaction price allocated to each performance obligation and amortize the costs accordingly. Commissions associated with licenses and license renewals are expensed at the time the corresponding licenses revenue is recognized. Commissions associated with subscription services are capitalized and amortized on a straight-line basis over a period of five years for initial contracts, reflecting our estimate of the expected period that we will benefit from those commissions. We determine the period of benefit by taking into consideration the length of our customer contracts, retention rate, the technology lifecycle, and other factors. Commissions paid on renewal contracts that are associated with subscription services are capitalized and amortized over the renewal term. We apply the practical expedient in ASC 340-40, Other Assets and Deferred Costs to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. We periodically review deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded for fiscal years 2024, 2023, or 2022. Cost of Revenue Licenses Cost of licenses revenue consists of all direct costs to deliver our licenses to customers, amortization of software development costs related to our licenses, and amortization of acquired developed technology. Subscription Services Cost of subscription services revenue consists of personnel-related expenses of our customer support and technical support teams, including salaries and bonuses, stock-based compensation expense, and employee b

Revenue Recognition

Revenue Recognition	12 Months Ended
	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	3 Revenue Recognition Disaggregation of Revenue The following table summarizes revenue by geographical region (dollars in thousands): Year Ended January 31, 2024 2023 2022 Amount Percentage of Amount Percentage of Amount Percentage of Americas (1) $ 631,923 48 % $ 529,060 50 % $ 430,326 48 % Europe, Middle East, and Africa 415,915 32 % 301,036 28 % 261,857 29 % Asia-Pacific (2) 260,234 20 % 228,485 22 % 200,069 23 % Total revenue $ 1,308,072 100 % $ 1,058,581 100 % $ 892,252 100 % (1) Revenue from the U.S. represented 43%, 46%, and 43% of our total revenues for fiscal years 2024, 2023, and 2022, respectively. (2) Revenue from Japan represented 9%, 10%, and 11% of our total revenues for fiscal years 2024, 2023, and 2022, respectively. Contract Balances Significant changes in our contract assets and deferred revenue balances during the periods presented were as follows (in thousands): Year Ended January 31, Contract Assets 2024 2023 Beginning balance $ 75,783 $ 77,561 Contract assets recognized during the year 84,180 74,265 Amounts transferred to accounts receivable from unbilled accounts receivable presented at the beginning of the year (69,260) (74,831) Translation adjustments (292) (1,212) Ending balance $ 90,411 $ 75,783 Contract assets, current $ 84,197 $ 69,260 Contract assets, non-current 6,214 6,523 Total contract assets $ 90,411 $ 75,783 Year Ended January 31, Deferred Revenue 2024 2023 Beginning balance $ 520,031 $ 366,020 Additions to deferred revenue during the year 1,364,473 1,145,584 Additions to deferred revenue from business acquisitions — 173 Revenue recognized that was included in deferred revenue at the beginning of the period (398,334) (297,355) Revenue recognized that was not included in deferred revenue at the beginning of the period (828,668) (687,603) Translation adjustments (9,670) (6,788) Ending balance $ 647,832 $ 520,031 Deferred revenue, current $ 486,805 $ 398,334 Deferred revenue, non-current 161,027 121,697 Total deferred revenue $ 647,832 $ 520,031 Remaining Performance Obligations Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of January 31, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $1,159.9 million , which consists of both billed consideration in the amount of $647.8 million and unbilled consideration in the amount of $512.1 million that we expect to recognize as revenue. We expect to recognize 61% of our remaining performance obligations as revenue in the next twelve months, and the remainder thereafter. Deferred Contract Acquisition Costs Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. The following table represents a rollforward of our deferred contract acquisition costs (in thousands): Year Ended January 31, 2024 2023 Beginning balance $ 187,503 $ 130,150 Additions to deferred contract acquisition costs 118,844 118,909 Amortization of deferred contract acquisition costs (75,471) (59,826) Translation adjustments (1,881) (1,730) Ending balance $ 228,995 $ 187,503 Deferred contract acquisition costs, current $ 74,678 $ 49,887 Deferred contract acquisition costs, non-current 154,317 137,616 Total deferred contract acquisition costs $ 228,995 $ 187,503

Marketable Securities

Marketable Securities	12 Months Ended
	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	4 Marketable Securities The following is a summary of our marketable securities (in thousands): As of January 31, 2024 Amortized Gross Gross Estimated Treasury bills and U.S government securities 641,263 29 (100) 641,192 Corporate bonds 1,993 — (2) 1,991 Agency bonds 174,990 — (28) 174,962 Total marketable securities $ 818,246 $ 29 $ (130) $ 818,145 As of January 31, 2023 Amortized Gross Gross Estimated Commercial paper $ 62,470 $ — $ — $ 62,470 Treasury bills and U.S government securities (1) $ 234,848 $ — $ (308) $ 234,540 Corporate bonds 46,684 — (198) 46,486 Municipal bonds 6,374 — (66) 6,308 Agency bonds 7,959 — (47) 7,912 Total marketable securities $ 358,335 $ — $ (619) $ 357,716 (1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less. As of January 31, 2024 and 2023, none and $2.9 million, respectively, of our marketable securities had remaining contractual maturities of one year or more. As of January 31, 2024 and 2023, $3.3 million and $3.5 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of January 31, 2024 or 2023. Unrealized losses during the period are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.

Fair Value Measurement

Fair Value Measurement	12 Months Ended
	Jan. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurement	5 Fair Value Measurement The following tables present our financial assets and liabilities measured at fair value on a recurring basis (in thousands): As of January 31, 2024 Level 1 Level 2 Total Financial Assets: Money market funds $ 509,053 $ — $ 509,053 Total cash equivalents 509,053 — 509,053 Treasury bills & U.S. government securities 641,192 — 641,192 Corporate bonds — 1,991 1,991 Agency bonds 174,962 — 174,962 Total marketable securities 816,154 1,991 818,145 Total $ 1,325,207 $ 1,991 $ 1,327,198 As of January 31, 2023 Level 1 Level 2 Total Financial Assets: Money market funds $ 319,801 $ — $ 319,801 Treasury bills 9,968 — 9,968 Total cash equivalents 329,769 — 329,769 Commercial paper — 62,470 62,470 Treasury bills and U.S. government securities 234,540 — 234,540 Corporate bonds — 46,486 46,486 Municipal bonds — 6,308 6,308 Agency bonds 7,912 — 7,912 Total marketable securities 242,452 115,264 357,716 Total $ 572,221 $ 115,264 $ 687,485 Our money market funds, treasury bills and U.S. government securities, and agency bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper, corporate bonds, and municipal bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. None of our financial instruments were classified as Level 3 as of January 31, 2024 and 2023.

Business Acquisitions

Business Acquisitions	12 Months Ended
	Jan. 31, 2024
Business Combination and Asset Acquisition [Abstract]
Business Acquisitions	6 Business Acquisitions Fiscal Year 2023 Acquisition Re:infer On July 29, 2022, we acquired all of the outstanding capital stock of Re:infer, a natural language processing company focused on unstructured documents and communications. Re:infer uses machine learning technology to mine context from communication messages and transform them into actionable data. With this acquisition, we gained technology and an experienced team which we believe will continue to accelerate our technology roadmap, expand the breadth of our AI-powered automation capabilities, and unlock new automation opportunities for our customers. The Re:infer acquisition was accounted for as a business combination. The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following: Cash paid at closing $ 30,117 Fair value of Class A common stock issued at closing (0.2 million shares) 2,965 Loan note paid on first anniversary of closing (July 29, 2023) 5,863 Loan note to be paid on second anniversary of closing (included in accrued expenses and other current liabilities as of January 31, 2024) 5,570 Working capital adjustment 66 Total $ 44,581 At closing, we also issued an additional 0.4 million shares of Class A common stock to be released to sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to certain employment-related clawback provisions. The aggregate fair value of these shares totaled $7.6 million and is expensed as compensation for post-acquisition services over the three years following the acquisition date. The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands): July 29, 2022 Net tangible assets $ 300 Intangible assets 13,100 Goodwill 34,351 Total assets acquired 47,751 Deferred tax liabilities assumed (3,170) Total $ 44,581 The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Estimated Useful Life Developed technology $ 10,000 5.0 Customer relationships 3,100 3.0 Total $ 13,100 The acquisition of Re:infer generated goodwill of $34.4 million representing expected synergies and acquired skilled workforce. None of this goodwill is deductible for tax purposes. We incurred transaction costs in connection with the Re:infer acquisition of $1.1 million, which were included in general and administrative expenses in the consolidated statement of operations for fiscal year 2023.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	12 Months Ended
	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	7 Intangible Assets and Goodwill Intangible Assets, Net Intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands): Intangible Accumulated Intangible Weighted-Average Developed technology $ 28,807 $ (16,881) $ 11,926 2.8 Customer relationships 8,266 (6,306) 1,960 1.3 Trade names and trademarks 272 (266) 6 0.2 Other intangibles 1,231 (419) 812 7.0 Total $ 38,576 $ (23,872) $ 14,704 Intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands): Intangible Accumulated Intangible Weighted-Average Developed technology $ 28,517 $ (11,095) $ 17,422 3.5 Customer relationships 8,174 (3,601) 4,573 2.0 Trade names and trademarks 272 (233) 39 1.2 Other intangibles 1,231 (255) 976 7.7 Total $ 38,194 $ (15,184) $ 23,010 We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the consolidated statements of operations. Amortization of acquired intangible assets was $8.6 million , $6.9 million and $5.1 million for fiscal years 2024, 2023, and 2022, respectively. Expected future amortization expense related to intangible assets was as follows as of January 31, 2024 (in thousands): Year Ended January 31, Amount 2025 $ 6,684 2026 4,105 2027 2,448 2028 1,163 2029 101 Thereafter 203 Total $ 14,704 Goodwill Changes in the carrying amount of goodwill were as follows during the periods presented (in thousands): Carrying Amount Balance as of January 31, 2022 $ 53,564 Acquisition of Re:infer 34,351 Effect of foreign currency translation 95 Balance as of January 31, 2023 88,010 Effect of foreign currency translation 1,016 Balance as of January 31, 2024 $ 89,026

Operating Leases

Operating Leases	12 Months Ended
	Jan. 31, 2024
Leases [Abstract]
Operating Leases	8 Operating Leases Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 14 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees. Lease costs are presented below (in thousands): Year Ended January 31, 2024 2023 2022 Operating lease cost $ 13,047 $ 11,675 $ 8,875 Short-term lease cost 4,965 5,895 4,387 Variable lease cost 2,142 1,418 582 Sublease income (1) (1,615) (2,129) (355) Total lease cost $ 18,539 $ 16,859 $ 13,489 (1) Included in other income (expense), net in the consolidated statements of operations Supplemental balance sheet information related to leases is as follows (in thousands): As of January 31, 2024 2023 Assets: Operating lease right-of-use assets $ 56,072 $ 52,052 Liabilities: Operating lease liabilities, current (included in accrued expenses and other current liabilities) $ 8,357 $ 6,997 Operating lease liabilities, non-current 58,713 56,442 Total operating lease liabilities $ 67,070 $ 63,439 Supplemental cash flow information related to operating leases is as follows for the periods presented (in thousands): Year Ended January 31, 2024 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 12,907 $ 6,702 $ 9,358 Operating lease ROU assets obtained in exchange for new operating lease liabilities $ 12,986 $ 11,511 $ 35,262 The following table represents the weighted-average remaining lease term and discount rate for the periods presented: As of January 31, 2024 2023 Weighted-average remaining lease term (years) 10.7 12.1 Weighted-average discount rate 7.1 % 7.0 % Future undiscounted lease payments for our operating lease liabilities as of January 31, 2024 were as follows (in thousands): Amount Year Ended January 31, 2025 $ 12,719 2026 11,838 2027 10,666 2028 9,012 2029 5,752 Thereafter 44,190 Total operating lease payments 94,177 Less: imputed interest (27,107) Total operating lease liabilities $ 67,070 As of January 31, 2024, we had non-cancellable commitments in the amount of $32.7 million related to operating leases of real estate facilities that have not yet commenced.

Consolidated Balance Sheet Comp

Consolidated Balance Sheet Components	12 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Consolidated Balance Sheet Components	9 Consolidated Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): As of January 31, 2024 2023 Prepaid expenses and service credits $ 87,781 $ 67,794 Other current assets 17,199 26,356 Prepaid expenses and other current assets $ 104,980 $ 94,150 Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of January 31, 2024 2023 Computers and equipment $ 23,767 $ 28,450 Leasehold improvements 21,756 19,622 Furniture and fixtures 6,640 6,485 Construction in progress 4,560 2,419 Other 632 — Property and equipment, gross 57,355 56,976 Less: accumulated depreciation (33,373) (27,931) Property and equipment, net $ 23,982 $ 29,045 Depreciation expense was $11.1 million , $8.6 million, and $6.8 million for fiscal years 2024, 2023, and 2022, respectively. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of January 31, 2024 2023 Accrued expenses $ 18,458 $ 19,411 Withholding tax from employee equity transactions 3,277 3,772 Employee stock purchase plan withholdings 3,618 3,365 Payroll taxes and other benefits payable 3,888 7,644 Income tax payable 7,140 8,750 Value-added taxes payable 6,480 6,381 Operating lease liabilities, current 8,357 6,997 Deferred consideration for business acquisition, current 5,570 5,863 Rebates payable to partners 7,289 — Other 19,920 14,462 Accrued expenses and other current liabilities $ 83,997 $ 76,645

Credit Facility

Credit Facility	12 Months Ended
	Jan. 31, 2024
Debt Disclosure [Abstract]
Credit Facility	10 Credit Facility On October 30, 2020 we entered into the Credit Facility, a $200 million senior secured revolving credit facility with a maturity date of October 30, 2023, with HSBC Ventures USA Inc., Silicon Valley Bank, a division of First Citizens Bank & Trust Company (successor by purchase to the FDIC as receiver for Silicon Valley Bridge Bank, N.A. (as successor to Silicon Valley Bank)), Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD. The Credit Facility contained certain customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions. We did not borrow under the Credit Facility at any time. In September 2023, we and the lenders terminated the Credit Facility prior to its original maturity date.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11 Commitments and Contingencies Letters of Credit We had a total of $2.6 million and $4.3 million in letters of credit outstanding predominantly in favor of certain landlords for office space as of January 31, 2024 and 2023, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2025. Indemnification In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties. These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of January 31, 2024 and 2023, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote. Workforce On June 24, 2022, our board of directors approved restructuring actions to manage our operating expenses by reducing our global workforce by approximately 5%. The workforce reduction aimed to simplify our go-to-market approach and improve sales productivity. In connection with these workforce reductions, we also ceased use of our office in Brooklyn, NY. On November 10, 2022, our board of directors approved further restructuring actions to reduce our global workforce across functions by an additional 6%. We incurred $2.6 million and $23.4 million of expense related to our restructuring actions in fiscal years 2024 and 2023, respectively. Our workforce restructuring actions were completed during the second quarter of fiscal year 2024. The following table shows the total amount incurred during fiscal years 2024 and 2023, and the related liability, which is recorded in accrued compensation and employee benefits in the consolidated balance sheets, for restructuring-related costs (in thousands): Accrued restructuring costs as of January 31, 2022 $ — Restructuring costs incurred during fiscal year 2023 $ 23,446 Amount paid during fiscal year 2023 $ (19,339) Write-off of assets associated with Brooklyn office $ (218) Accrued restructuring costs as of January 31, 2023 $ 3,889 Restructuring costs incurred during fiscal year 2024 2,626 Amount paid during fiscal year 2024 (6,180) Accrued restructuring costs as of January 31, 2024 $ 335 The following table presents the restructuring charges incurred (in thousands): Year Ended January 31, 2024 2023 Employee Termination Benefits Lease Exit Costs Total Restructuring Costs Employee Termination Benefits Lease Exit Costs Total Restructuring Costs Cost of subscription services revenue $ 114 $ — $ 114 $ 76 $ 106 $ 182 Cost of professional services and other revenue — — — 585 125 710 Sales and marketing 1,376 — 1,376 18,965 526 19,491 Research and development 387 — 387 448 46 494 General and administrative 749 — 749 2,192 377 2,569 Total $ 2,626 $ — $ 2,626 $ 22,266 $ 1,180 $ 23,446 Defined Contribution Plans We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. a nd defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans during fiscal years 2024, 2023, and 2022 were $16.0 million , $14.5 million, and $10.4 million, respectively. Litigation From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters which arise in the ordinary course of business. In accordance with ASC 4 50, Contingencies , we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. UiPath and certain of its officers are currently parties to the following litigation matters: On September 6, 2023, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, then Co-CEO Daniel Dines, and CFO Ashim Gupta, captioned In re UiPath, Inc. Securities Litigation (the Securities Action ) . The lawsuit asserts claims under Sections 10(b) and 20(a) of the Exchange Act, and alleges that defendants made material misstatements and omissions, including regarding UiPath’s competitive position and its financial results. On January 26, 2024, the lead plaintiff in the Securities Action filed an amended complaint. On March 26, 2024, the plaintiffs filed a further amended complaint, which alleges Securities Acts claims under Sections 11 and 15 as well as Exchange Act claims under Section 10(b), Rule 10b-5, and Section 20(a). In support of the Securities Act claims, the plaintiff alleges material misstatements and omissions in UiPath’s April 2021 Registration Statement, including regarding UiPath’s competitive position and its financial results. The operative complaint is purportedly brought on behalf of a putative class of persons who purchased or otherwise acquired UiPath common stock between April 21, 2021 and September 27, 2022. It seeks unspecified monetary damages, costs and attorneys’ fees, and other unspecified relief as the Court deems appropriate. On November 30, 2023, a purported shareholder derivative lawsuit was filed in the United States District Court for the Eastern District of New York against UiPath, as nominal defendant, and then Co-CEO Daniel Dines, CFO Ashim Gupta, and several of UiPath’s current and former directors. The case is captioned Polilingua Limited v. Daniel Dines, et al . The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements at issue in the Securities Action and by causing UiPath to repurchase shares at allegedly inflated prices. The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys’ fees and certain changes to UiPath’s corporate governance and internal controls. Similar cases were filed in the District of Delaware and in the Southern District of New York (together with Polilingua Limited v. Daniel Dines, et al, the Derivative Litigations ). The Derivative Litigations are at an early stage; in each case the matter has been stayed, pending the outcome of the Court's decision on the defendants' anticipated motion to dismiss the Securities Action. We have not recorded any accrual related to the aforementioned litigation matters as of January 31, 2024, as we believe a loss in these matters is neither probable nor estimable at this time. Warranty We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made. Other Matters Our indirect tax positions are subject to audit in multiple jurisdictions globally. Our Romanian subsidiary is currently undergoing final audit procedures related to value-added tax for the period from January 2020 through January 2022. We have not recorded any accrual related to this audit as of January 31, 2024 as it is not probable that a loss has been incurred. Non-Cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services and software products and services. As of January 31, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Year Ended January 31, Amount 2025 $ 68,958 2026 70,597 2027 23,092 2028 8,450 2029 18 Thereafter — Total $ 171,115

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	12 Months Ended
	Jan. 31, 2024
Equity [Abstract]
Stockholders' Equity	12 Stockholders' Equity Common Stock In April 2021, we amended and restated our certificate of incorporation, which authorized a total of 2.0 billion shares of Class A common stock and 115.7 million shares of Class B common stock. Each share of Class B common stock will convert automatically into Class A common stock, on a one-to-one basis, upon certain circumstances, including: (1) the sale or transfer of such share of Class B common stock (except under certain circumstances described in the amended and restated certificate of incorporation), (2) a date fixed by the board of directors that is no less than 120 days and no more than 180 days following the date that the number of shares of Class B common stock outstanding is less than 20% of the number of shares of Class B common stock outstanding immediately prior to the completion of the IPO, or (3) six months after the death or incapacity of Daniel Dines. Class A common stock is entitled to one vote per share and Class B common stock is entitled to thirty-five votes per share. Stock Repurchase Program On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization expires on March 1, 2025, subject to modification by the board of directors in the future. From the inception of the share repurchase program through January 31, 2024, we have repurchased 5.8 million shares of our Class A common stock at an average price of $17.57 per share (inclusive of brokerage commission). Subsequent to January 31, 2024, between February 1, 2024 and March 12, 2024, we repurchased an additional 0.9 million shares of our Class A common stock at an average price of $23.46 per share. Charitable Donations of Class A Common Stock We have reserved 2.8 million shares of our Class A common stock to fund our social impact and ESG initiatives. We contributed 0.3 million shares of our Class A common stock during fiscal year 2024 and 0.3 million of our Class A common stock during fiscal year 2023 to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair values of the shares on the respective contribution dates of $4.2 million and $5.5 million were recorded within general and administrative expense in the consolidated statements of operations for fiscal years 2024 and 2023, respectively. Preferred Stock In April 2021, we amended and restated our certificate of incorporation, which authorized a total of 20.0 million shares of preferred stock. Dividends Holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the priority rights of holders of preferred stock. No dividends have been declared by the board of directors from inception through January 31, 2024. Accumulated Other Comprehensive Income (Loss) Changes in the components of accumulated other comprehensive income (loss) were as follows during the periods presented (in thousands): Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2022 $ 11,234 $ (335) $ 10,899 Other comprehensive loss, net of tax (3,003) (284) (3,287) Balance as of January 31, 2023 $ 8,231 $ (619) $ 7,612 Other comprehensive income, net of tax 694 519 1,213 Balance as of January 31, 2024 $ 8,925 $ (100) $ 8,825

Equity Incentive Plans and Stoc

Equity Incentive Plans and Stock-Based Compensation	12 Months Ended
	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans and Stock-Based Compensation	13 Equity Incentive Plans and Stock-Based Compensation 2021 Stock Plan In April 2021, prior to and in connection with the IPO, we adopted the 2021 Plan , which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, RSAs, RSUs, PSUs, and other forms of awards. As of January 31, 2024, w e have reserved 173.7 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase. 2021 Employee Stock Purchase Plan In April 2021, prior to and in connection with the IPO, we adopted the ESPP. As of January 31, 2024, t he ESPP authorizes the issuance of 21.5 million shares of our Class A common stock under purchase rights granted to our employees. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of 10 years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except that before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a) 85% of the fair market value our Class A common stock as of the commencement of the offering period, and (b) 85% of the fair market value of our Class A common stock on the corresponding purchase date. Prior Stock Plans In June 2015, we adopted the 2015 Plan . The 2015 Plan was terminated in June 2018 in connection with the adoption of the 2018 Plan . Accordingly, no shares are available for future issuance under the 2015 Plan following the adoption of the 2018 Plan. In June 2018, we adopted the 2018 Plan, which provided for grants of stock-based awards, including RSUs, RSAs, and stock options. The 2018 Plan was terminated in April 2021 in connection with the adoption of the 2021 Plan. Accordingly, no shares are available for future issuance under the 2018 Plan following the adoption of the 2021 Plan. Outstanding Equity Awards Stock Options Stock options generally vest over three Options Outstanding Stock Options (in thousands) Weighted-Average Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Balance as of January 31, 2023 13,898 $ 3.32 7.7 $ 169,324 Granted 2,995 $ 0.10 Exercised (5,221) $ 1.29 Forfeited (592) $ 1.80 Expired — $ — Balance as of January 31, 2024 11,080 $ 3.49 7.8 $ 216,010 Vested and exercisable as of January 31, 2024 4,990 $ 4.59 6.6 $ 91,793 The weighted-average grant date fair value of stock options granted during fiscal years 2024, 2023, and 2022 was $16.84, $12.23 and $45.78 per share, respectively. The intrinsic value of stock options exercised during fiscal years 2024, 2023, and 2022 was $93.2 million, $83.6 million, and $557.5 million, respectively. As of January 31, 2024, unrecognized compensation expense associated with unvested stock options granted and outstanding was $102.5 million, to be recognized over a weighted-average remaining period of 2.1 years. Fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions: Year Ended January 31, 2024 2023 2022 Expected term (years) 5.9 5.9 6.1 Expected volatility 65.2% 60.6% 57.2% Risk-free interest rate 3.6% 3.5% 1.4% Expected dividend yield 0.0% 0.0% 0.0% During fiscal years 2023 and 2022, our compensation committee approved modifications to allow acceleration of the service-based vesting condition of certain employee stock options upon termination. These modifications, which were considered improbable-to-probable (Type 3) modifications under ASC 718, resulted in accelerated vesting of 0.3 million and 0.2 million shares, respectively, of Class A common stock subject to outstanding stock options, and incremental compensation expense of $2.8 million and $2.9 million was recognized during fiscal years 2023 and 2022, respectively. Early Exercised Options Certain stock option holders have the right to exercise unvested options, subject to a repurchase right held by us at the original exercise price in the event of voluntary or involuntary termination of employment of the option holders, until the options are fully vested. During fiscal year 2024, we did not repurchase any unvested early exercised options. During fiscal year 2023, we repurchased $0.4 million unvested early exercised options in the amount of $1.5 million. Cash proceeds associated with early exercises are recorded within accrued expenses and other current liabilities and other liabilities, non-current in our consolidated balance sheets, depending on the future vesting dates of the associated options. Such accrued amounts were not material as of January 31, 2024 and 2023. Proceeds are transferred to additional paid-in capital at the time of option vesting. Restricted Stock Units RSUs granted under th e 2021 Plan g enerally vest over three RSU activity during fiscal year 2024 was as follows: RSUs (in thousands) Weighted-Average Grant Unvested as of January 31, 2023 36,785 $ 22.48 Granted 19,274 $ 16.95 Vested (17,556) $ 20.64 Forfeited (7,231) $ 23.39 Unvested as of January 31, 2024 31,272 $ 19.89 The fair value of RSUs released during fiscal years 2024, 2023, and 2022 was $329.6 million , $228.8 million, and $1.4 billion, respectively. Prior to the IPO, we granted RSUs under th e 2018 Plan that vested upon the satisfaction of both a service-based condition (generally four years) and a performance-based condition. The performance-based vesting condition was deemed satisfied on April 23, 2021, the date that our IPO was completed. At that time (during fiscal year 2022), we recognized $233.0 million of cumulative stock-based compensation expense for the portion of these RSUs for which the service-based vesting condition had been fully or partially satisfied. As of January 31, 2024, unrecognized compensation expense associated with unvested RSUs was approximately $560.5 million, to be recognized over a weighted-average remaining period of 2.3 years. During fiscal year 2023, our compensation committee approved modifications to allow accelerated vesting of approximately 0.5 million RSUs upon employee terminations. The modifications, which were considered improbable-to-probable (Type 3) modifications under ASC 718, resulted in a net reduction of $7.4 million in the fair value of the modified awards due to the decrease in our stock price between the grant and modification dates. During fiscal year 2022, our compensation committee approved modifications to allow accelerated vesting of approximately 0.2 million RSUs upon employee terminations, resulting in the recognition of $10.9 million of incremental expense. Performance Stock Units In July 2023, we granted approximately 0.1 million PSUs at a grant date fair value of $18.08 per share. The PSUs were subject to performance conditions related to the achievement of certain individual and company targets for fiscal year 2024, which were not met. As a result, the PSUs have been cancelled and no expense was recognized during fiscal year 2024. Employee Stock Purchase Plan Awards The fair value of ESPP awards was estimated using the Black-Scholes option pricing model with the following weighted-average assumptions: Year Ended January 31, 2024 2023 2022 Expected term (years) 0.5 0.5 0.6 Expected volatility 67.4% 69.0% 55.7% Risk-free interest rate 5.02% 1.86% 0.05% Expected dividend yield 0.0% 0.0% 0.0% During the fiscal year ended January 31, 2024, 1.4 million shares were purchased under the ESPP at a weighted average purchase price of $12.69 per share. As of January 31, 2024, unrecognized compensation expense related to the ESPP was approximately $3.0 million, to be recognized over a weighted-average remaining period of 0.4 years. Stock-Based Compensation Associated with Business Acquisition At the closing of the acquisition of Re:infer on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) to be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of January 31, 2024, total unrecognized compensation expense related to these shares was $3.8 million, which is to be recognized over a weighted-average remaining period of 1.5 years. Stock-Based Compensation Expense Stock-based compensation expense is classified in the consolidated statements of operations as follows (in thousands): Year Ended January 31, 2024 2023 2022 (1) Cost of subscription services revenue $ 14,750 $ 11,894 $ 12,232 Cost of professional services and other revenue 10,958 11,855 29,849 Sales and marketing 144,863 154,922 237,975 Research and development 117,965 102,546 135,713 General and administrative 83,419 88,623 99,814 Total $ 371,955 $ 369,840 $ 515,583 (1) Presented net of capitalized stock-based compensation relating to software development costs of $4.5 million.

Income Taxes

Income Taxes	12 Months Ended
	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	14 Income Taxes The U.S. and foreign components o f loss before income taxes are as follows for the periods presented (in thousands): Year Ended January 31, 2024 2023 2022 U.S. $ (168,587) $ (273,467) $ (306,814) Foreign 92,772 (44,094) (204,069) Loss before income taxes $ (75,815) $ (317,561) $ (510,883) The components of the provision for income taxes are as follows for the periods presented (in thousands): Year Ended January 31, 2024 2023 2022 Current expense (benefit) Federal $ (106) $ 213 $ — State (166) 493 80 Foreign 13,786 9,224 20,455 Total current expense 13,514 9,930 20,535 Deferred expense (benefit) Federal — — — State — — — Foreign 554 861 (5,832) Total deferred expense (benefit) $ 554 $ 861 $ (5,832) Total provision for income taxes $ 14,068 $ 10,791 $ 14,703 The following is a reconciliation of the statutory federal income tax rate to our effective tax rate for the periods presented: Year Ended January 31, 2024 2023 2022 Federal statutory income tax rate 21.0 % 21.0 % 21.0 % Foreign taxes (2.0) (2.2) (3.7) Non-deductible expenses (17.9) (2.1) (2.7) Stock-based compensation (4.6) (10.8) 27.1 Valuation allowance (5.7) (12.3) (48.2) Research and development credits 18.9 3.3 3.8 Cross border tax law (27.4) — — Other, net (0.9) (0.3) (0.2) Effective income tax rate (18.6) % (3.4) % (2.9) % Significant components of DTAs and DTLs are as follows as of the periods presented (in thousands): As of January 31, 2024 2023 Deferred tax assets: Net operating loss carryforwards $ 344,067 $ 387,822 Accruals and reserves 15,823 15,072 Stock-based compensation 11,888 25,665 Deferred revenue 25,942 9,477 Research and development 103,263 67,103 Depreciation and amortization 587 587 Excessive borrowing — 1,668 Lease liabilities (1) 11,563 — Other (1) 5,602 7,406 Total deferred tax assets, gross 518,735 514,800 Less: valuation allowance (470,040) (476,589) Total deferred tax assets, net of valuation allowance 48,695 38,211 Deferred tax liabilities: Intangible assets (2,409) (3,312) Foreign exchange (37) (97) Right-of-use assets (1) (8,957) — Commissions (32,747) (29,245) Total deferred tax liabilities (44,150) (32,654) Net deferred tax assets $ 4,545 $ 5,557 Net deferred tax assets $ 4,678 $ 5,895 Net deferred tax liabilities (included in other liabilities, non-current) (133) (338) Net deferred tax assets $ 4,545 $ 5,557 (1) As of January 31, 2023, immaterial amounts related to lease liabilities and right-of-use assets and were presented as part of "Other." In preparing the provision for income taxes, we assess the available positive and negative evidence to determine whether sufficient future taxable income will be generated to permit the use of existing deferred tax assets. A significant piece of objective negative evidence was the cumulative loss we incurred over the three-year period ending January 31, 2024. Such objective evidence outweighs other subjective evidence, such as our projections for future growth. Based on such evaluation we determined as of January 31, 2024 that it was more likely than not that the deferred tax assets will not be realized. Accordingly, we recorded a full valuation allowance against U.S. federal and state, Romanian, and U.K. DTAs as of January 31, 2024, consistent with January 31, 2023. However, we may release some of these valuation allowances in future periods if objective negative evidence of cumulative losses is no longer present and positive evidence, such as projection of future growth, supports the realization of such deferred tax assets. Release of all or a portion of these valuation allowances would result in a decrease in the provision for income taxes in the period of the release. The table below details the changes in DTA valuation allowances for the periods presented (in thousands): Beginning Additions During the Period Reductions During the Period Ending Year ended January 31, 2024 $ 476,589 $ 5,474 $ (12,023) $ 470,040 Year ended January 31, 2023 $ 422,262 $ 54,327 $ — $ 476,589 The reduction in valuation allowance during fiscal year 2024 was driven by a decrease in our deferred tax assets in Romania and the U.K. As of January 31, 2024, we had U.S. federal NOLs As of January 31, 2024 and 2023, we had state NOLs of $824.7 million and $771.5 million, respectively, which begin expiring in 2025. As of January 31, 2024 and 2023, we had Romanian NOLs of $549.9 million and $601.6 million, respectively, which begin expiring in 2025. As of January 31, 2024 and 2023, we had Japanese NOLs of $6.3 million and $10.4 million, respectively, which begin expiring in 2027. Additionally, as of January 31, 2024 and 2023, we had U.K. NOLs of $118.3 million and $135.1 million, respectively, which may be carried forward indefinitely. Pursuant to Section 382 of the IRC, annual use of our U.S. NOLs may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. We determined that two such ownership changes have occurred. The first resulted in an annual limitation, independent of net unrealized built-in gains, of $0.1 million for our NOLs as of April 24, 2017 but did not result in permanent disallowance of any NOLs. The second resulted in an annual limitation, independent of net unrealized built-in gains, of $29.0 million for our NOLs as of July 9, 2020 but did not result in permanent disallowance of any NOLs. We do not provide for deferred taxes on $109.2 million of the undistributed earnings of our foreign subsidiaries as of January 31, 2024, because we intend to indefinitely reinvest such undistributed earnings in our non-U.S. operations. As of January 31, 2024, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $0.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. As of January 31, 2023, we had gross unrecognized tax benefits of $2.3 million. Of this amount, the total liability pertaining to uncertain tax positions was $0.5 million, excluding interest and penalties. Our tax positions are subject to income tax audits in multiple tax jurisdictions globally, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. Our Romanian subsidiary is currently undergoing final procedures in the audit for tax years from 2017 through 2022. Our Indian subsidiary is currently going through the administrative dispute process for the audit for tax years from 2019 through 2021. We file income tax returns in the U.S. federal jurisdiction, various state jurisdictions, and various international jurisdictions. Tax years 2020 and forward generally remain open for examination for federal and state tax purposes. Tax years 2017 and forward generally remain open for examination for foreign tax purposes. To the extent utilized in future years’ tax returns, NOLs at January 31, 2024 and 2023 will remain subject to examination until the respective tax year is closed.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	12 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	15 Net Loss Per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts): Year Ended January 31, 2024 2023 2022 Class A Class B Class A Class B Class A Class B Numerator: Net loss $ (76,739) $ (13,144) $ (278,950) $ (49,402) $ (423,296) $ (102,290) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 481,402 82,453 465,569 82,453 366,146 88,479 Net loss per share attributable to common stockholders, basic and diluted $ (0.16) $ (0.16) $ (0.60) $ (0.60) $ (1.16) $ (1.16) Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands): Year Ended January 31, 2024 2023 2022 Class A Class B Class A Class B Class A Class B Convertible preferred stock — — — — 68,015 — Unvested RSUs 36,878 — 31,427 — 23,237 — Outstanding stock options 13,247 — 13,967 — 18,424 — Shares subject to repurchase from RSAs and early exercised stock options 52 — 284 — 1,539 — Shares issuable under ESPP 705 — 828 — 312 — Returnable shares issued in connection with business acquisition 349 — 219 — — — Total 51,231 — 46,725 — 111,527 —

Related Party Transactions

Related Party Transactions	12 Months Ended
	Jan. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	16 Related Party Transactions Beginning in the third quarter of fiscal year 2022, we have at times made use of an aircraft which is owned by Daniel Dines, our co-founder and then CEO, through a special purpose LLC and which is operated by a third-party aircraft management company. Mr. Dines, through this special purpose LLC, obtained financing for the aircraft and bears all associated operating, personnel, and maintenance costs for the aircraft. We determined at the inception of this arrangement that the LLC is a VIE of which we are not the primary beneficiary; accordingly, we do not consolidate it in our consolidated financial statements. We did not incur any expense related to the use of the aircraft in fiscal year 2024. In fiscal year 2023 and 2022, we incurred expenses of $1.9 million and $1.1 million, respectively, in connection with our business use of the aircraft.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (89,883)	$ (328,352)	$ (525,586)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Jan. 31, 2024 shares	Jan. 31, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Richard P. Wong [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On January 12, 2024, Richard P. Wong, a member of our board of directors, on behalf of a family trust, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act to sell, between April 15, 2024 and July 15, 2024, up to 150,000 shares of our Class A common stock, subject to limit prices
Name	Richard P. Wong
Title	member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	January 12, 2024
Arrangement Duration	91 days
Aggregate Available	150,000	150,000
Brad Brubaker [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On January 12, 2024, Brad Brubaker, our Chief Legal Officer and Secretary, terminated the remaining portion of his Rule 10b5-1 trading arrangement originally adopted on January 11, 2023 for the sale of up to 165,000 shares of our Class A common stock through February 28, 2024.
Name	Brad Brubaker
Title	Chief Legal Officer and Secretary
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	January 11, 2023
Rule 10b5-1 Arrangement Terminated	true
Termination Date	January 12, 2024
Aggregate Available	165,000	165,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jan. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The consolidated financial statements have been prepared in accordance with U.S. GAAP and include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation.
Fiscal Year	Fiscal Year Our fiscal year ends on January 31. References to fiscal years 2024, 2023, and 2022 refer to the fiscal years ended January 31, 2024, 2023, and 2022, respectively.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease ROU assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense including determination of fair value of common stock prior to our IPO, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency	Foreign Currency
Derivative Financial Instruments	Derivative Financial Instruments From time to time, we use derivative financial instruments, such as foreign currency forward contracts, to manage foreign currency exposures. We account for our derivative instruments as either assets or liabilities and carry them at fair value. These foreign currency contracts are not designated and do not qualify as hedging instruments, as defined by ASC 815, Derivatives and Hedging
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where deposits, at times, exceed FDIC limits. As of January 31, 2024 and 2023, 91% and 98%, respectively, of our cash and cash equivalents were concentrated in the U.S., EU countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.
Fair Value of Financial Instruments	Fair Value of Financial Instruments We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. We determine fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: Level 1—Quoted prices in active markets for identical assets or liabilities that we can access at the measurement date. Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, such as: • quoted prices for similar assets or liabilities in active markets; • quoted prices for identical or similar assets or liabilities in markets that are not active; or • inputs other than quoted prices that are observable or can be corroborated by observable market data. Level 2 inputs must be observable for substantially the full term of the asset or liability. Level 3—Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair value. Financial instruments consist of cash equivalents, marketable securities, accounts receivable, and accounts payable. Marketable securities are recorded at fair value. Cash equivalents, accounts receivable and accounts payable are recorded at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date.
Cash and Cash Equivalents	Cash and Cash Equivalents We consider all highly liquid investments purchased with original maturity dates of three months or less to be cash equivalents.
Marketable Securities	Marketable Securities Our marketable securities consist of corporate bonds, municipal bonds, agency bonds, treasury bills and U.S. government securities, and commercial paper with original maturity dates of more than three months from the date of purchase. We determine the appropriate classification of our marketable securities at the time of purchase and reevaluate such designation at each balance sheet date. We have classified and accounted for our marketable securities as available-for-sale securities based on our intentions with regard to these instruments, and we classify them as current or non-current assets in the consolidated balance sheets based on their stated maturity dates. The fair value of available-for-sale marketable securities is remeasured each reporting period. Any premiums and discounts are amortized or accreted over the life of the related available-for-sale security as an adjustment to yield. Interest income is recognized when earned. Unrealized gains and losses on marketable securities are reported as a separate component of accumulated other comprehensive income on the consolidated balance sheets until realized.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses
Property and Equipment, Net	Property and Equipment, Net Property and equipment are recorded at historical cost, less accumulated depreciation. Property and equipment are depreciated on a straight-line basis over the estimated useful lives of the assets. Useful lives by asset category are as follows: Asset Category Estimated Useful Life Computer and equipment 1 to 2 years Furniture and fixtures 2 to 9 years Leasehold improvements Shorter of remaining lease term or estimated useful life (1 to 14 years)
Internal-Use Software	Internal-Use Software Pursuant to ASC 350-40, Internal Use Software , we capitalize costs incurred to implement cloud computing arrangements that are service contracts and costs incurred to develop internal-use software, which has historically included our SaaS products. ASC 350-40 prescribes capitalization of costs incurred during the application development stage, costs incurred to develop or obtain software that allows for access to or conversion of old data by new systems, and costs incurred in connection with upgrades and enhancements to internal-use software if it is probable that such expenditures will result in additional functionality. These capitalized costs exclude training costs, project management costs, and data migration costs. We evaluate our long-lived assets, including these capitalized costs, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable. Beginning in the fourth quarter of fiscal year 2022, we began to broadly market on-premises versions of certain of our SaaS products, thereby establishing a pattern of marketing internal-use software and a rebuttable presumption that we intend to market any SaaS products we develop. As a result, our ongoing and future SaaS projects must be accounted for under ASC 985-20, Costs of Software to be Sold, Leased or Marketed, which is discussed below under "Software Development Costs." Costs previously capitalized under ASC 350-40 in connection with development of our SaaS products are amortized on a straight-line basis over the product’s estimated useful life of five years and are included in cost of subscription services revenue on the consolidated statements of operations. Capitalized costs include salaries, benefits, and stock-based compensation charges for employees that are directly involved in developing our SaaS products. These capitalized costs are included in other assets, non-current on the consolidated balance sheets. Gross capitalized internal-use software development costs were $7.5 million as of January 31, 2024 and 2023. Amortization expense was $1.3 million, $1.3 million, and $1.2 million for fiscal years 2024, 2023, and 2022, respectively. Accumulated amortization was $4.3 million and $3.0 million as of January 31, 2024 and 2023, respectively.
Software Development Costs	Software Development Costs We account for costs incurred to develop software to be licensed in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed . These costs include internal development costs and license fees paid to third parties for their software that is integrated into our products. Beginning in the fourth quarter of fiscal year 2022, we also account for costs incurred to develop our SaaS products in accordance with ASC 985-20. This guidance requires that all costs to establish technological feasibility be expensed as they are incurred. Technological feasibility is established when the working model is complete. Costs incurred subsequent to establishing technological feasibility are capitalized until the product is available for general release to customers, at which point they are amortized on a product-by-product basis. Management evaluates the useful life of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact their recoverability. Our internal development costs are amortized over the estimated useful life of the software, which is five years, on a straight-line basis, and are included in cost of licenses revenue or cost of subscription services revenue in the consolidated statements of operations based on the nature of the underlying product. Capitalized costs include salaries, benefits, and stock-based compensation charges for employees that are directly involved in developing our products. Capitalized costs are included in other assets, non-current on the consolidated balance sheets. Gross capitalized software development costs were $4.2 million and $4.3 million as of January 31, 2024 and 2023, respectively. Related amortization expense was $0.9 million, $0.9 million, and $0.7 million for fiscal years 2024, 2023 and 2022, respectively. Accumulated amortization was $3.0 million and $2.1 million as of January 31, 2024 and 2023, respectively.
Leases	Leases We determine if an arrangement contains a lease at inception based on whether there is an identified asset and whether we control the use of the identified asset throughout the period of use. We classify leases as either financing or operating leases. We do not have any financing leases. Operating lease liabilities represent our obligation to make payments arising from a lease. Operating lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. The present value of lease payments is discounted based on our incremental borrowing rate unless the rate implicit in the lease is readily determinable, which generally is not the case. We estimate our incremental borrowing rate based on information available at the lease commencement date for collateralized borrowings with a similar term, amount, borrower creditworthiness, and economic environment. Operating lease ROU assets represent our right to use an underlying asset for the lease term. Our operating lease ROU assets are measured based on the corresponding operating lease liability adjusted for (1) payments made to the lessor at or before the commencement date, (2) initial direct costs incurred, and (3) tenant incentives under the lease. Options to renew or terminate the lease are recognized as part of our operating lease ROU assets and operating lease liabilities when it is reasonably certain the options will be exercised. We have elected to not separate lease and non-lease components for any leases within our existing classes of assets. Operating lease expense for fixed lease payments is recognized on a straight-line basis over the lease term. Variable lease payments for real estate taxes, insurance, maintenance, and utilities, which are generally based on our pro-rata share of the total property, are expensed as incurred and are not included in the measurement of the operating lease ROU assets or operating lease liabilities. In addition, we do not recognize ROU assets and lease liabilities for short-term leases which have a lease term of 12 months or less and do not include an option to purchase the underlying asset that we are reasonably certain to exercise. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.
Business Acquisitions	Business Acquisitions Assets acquired and liabilities assumed in a business combination are recorded at their respective fair values at the date of the acquisition in accordance with ASC 805, Business Combinations (with the exception of contract assets and contract liabilities, which are measured according to ASC 606, Revenue from Contracts with Customers, discussed under "Revenue Recognition," below). Determination of the fair value of assets acquired and liabilities assumed relies on management judgments and often involves the use of estimates and assumptions, including but not limited to assumptions about future cash inflows and outflows, discount rates, and lives of intangible and other assets. Any excess of the purchase price over the fair value of the net assets acquired is recognized as goodwill. During the one-year measurement period following an acquisition, we may record adjustments to the fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, subsequent adjustments, if any, are recorded in our consolidated statements of operations. Acquisition costs, such as legal and consulting fees, are expensed as incurred.
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets Goodwill represents the excess of the purchase price in a business acquisition over the fair value of the net assets acquired and is not amortized. We test goodwill for impairment at the reporting unit level at least annually in November and may test more frequently when events or changes in circumstances indicate that the carrying value may not be recoverable. At the time of testing, if we determine that it is more likely than not that the estimated fair value of our single reporting unit is less than its carrying value, a quantitative assessment is performed by comparing the fair value of the reporting unit with its carrying value. In order to make this determination, we may make an initial assessment of qualitative factors, or may proceed directly to the quantitative impairment test. There were no impairment charges to goodwill during fiscal years 2024, 2023, and 2022. Acquired intangible assets consist primarily of developed technology and customer relationships resulting from our business acquisitions. Intangible assets are recorded at fair value on the date of acquisition and are amortized over their estimated useful lives.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets We evaluate our long-lived assets for indicators of possible impairment when events or changes in circumstances suggest that the carrying amount of an asset or asset group may not be recoverable. We assess recoverability by comparing the carrying amount of such asset or asset group to the net undiscounted future cash flows we expect the asset or asset group to generate. If the carrying amount of an asset or asset group exceeds the related undiscounted cash flows, it is considered to be impaired and an impairment charge is recognized for the amount by which the carrying value of the asset or asset group exceeds its fair value. There were no events or changes in circumstances during fiscal years 2024, 2023, or 2022 which indicated potential impairment of our long-lived assets.
Revenue Recognition	Revenue Recognition We derive revenue from the sale of: (1) software licenses for on-premise use of our proprietary software and related maintenance and support; (2) the right to access certain software products we host (i.e., SaaS); and (3) professional services. For many of our products that are available both on-premise and via SaaS, we sell a single offering that allows customers the choice of either on-premise or SaaS deployment throughout the term of the contract. These Flex Offerings are comprised of three types of performance obligations: term license, maintenance and support, and SaaS. In accordance with ASC 606, Revenue from Contracts with Customers , revenue is recognized when or as a customer obtains control of the distinct promised goods and services. The amount of revenue recognized reflects the consideration to which we expect to be entitled in exchange for those goods or services. To achieve the core principle of ASC 606, we apply the following five steps: 1. Identification of the contract, or contracts, with the customer; 2. Identification of the performance obligations in the contract; 3. Determination of the transaction price; 4. Allocation of the transaction price to the performance obligations in the contract; and 5. Recognition of the revenue when, or as, a performance obligation is satisfied. Our significant performance obligations and our application of ASC 606 to each of those performance obligations are discussed in further detail below. Payment terms and conditions vary by contract type, although terms generally require payment within 30 to 60 days of the invoice date. In certain arrangements, we receive payment from a customer either before or after the performance obligation has been satisfied; however, our contracts do not contain a significant financing component. The primary purpose of our invoicing terms is to provide customers with simplified and predictable ways of purchasing our products and services, not to receive financing from our customers or to provide customers with financing. We apply the practical expedient in ASC 606 and do not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recorded net of sales tax. We generally do not offer a right of refund in our contracts. Licenses Our term licenses (typically sold as a portion of Flex Offerings), provide customers the right to use software for a specified period of time. Revenue for licenses is recognized at the point in time at which the customer is able to use and benefit from the software, which is generally upon delivery to the customer or upon commencement of the renewal term. For licenses revenue, we generally invoice when the license(s) are provided or annually at contract anniversary. Subscription Services We generate subscription services revenue through the provision of: (1) maintenance and support, which include technical support and unspecified updates and upgrades on a when-and-if-available basis for our licenses, and (2) SaaS products (typically sold as a portion of Flex Offerings). Maintenance and support represent stand-ready obligations for which revenue is recognized ratably over the term of the arrangements. For maintenance and support, we generally invoice when the associated license(s) are provided or annually at contract anniversary. Customers do not have the contractual right to take possession of the software underlying our SaaS products. Therefore, SaaS products are stand-ready obligations to provide access to our products, and the related revenue is recognized ratably over the contractual term of the arrangement, as control of the services is transferred to the customer. We generally invoice for our SaaS products when the customer is provided access and may begin using the SaaS products or annually at contract anniversary. Professional Services and Other Professional services and other revenue consists of fees associated with professional services for process automation, customer education, and training services. Our professional services contracts are structured on a time and materials or fixed price basis, and the related revenue is recognized as the services are rendered. We use a cost-based input method as the measure of progress toward satisfying the performance obligation. For professional services, we invoice as the services are provided or in advance. Contracts with Multiple Performance Obligations Most of our contracts with customers contain multiple performance obligations. The transaction price is allocated to the separate performance obligations on a relative SSP basis. Whenever possible, we allocate the transaction price based on observable SSP, which is the price of the same good or service in standalone sales to similar customers in similar circumstances. If observable SSP is not available, we estimate the SSP using data that may include historical prices, discounting practices, list prices, cost data, and other observable inputs. Our SSP reflects the amount we would charge for each performance obligation if it were sold separately in standalone sales to similar customers in similar circumstances in similar geographies. Consideration Payable to Customers From time to time, we enter into arrangements wherein we sell our products and services to a customer or partner while also making commitments to purchase products or services from that customer or partner or make investments to enable that customer or partner to create or enhance their automation practice. These commitments are treated as consideration payable to a customer, and therefore as a reduction to the transaction price, when it is determined that the payment is not in exchange for a distinct good or service that is priced at fair market value. If the consideration payable includes a variable amount, we estimate the transaction price, including assessing whether the estimate of variable consideration must be constrained. We also offer certain rebate incentives to our partners which are treated as consideration payable to a customer and therefore accounted for as a reduction to the transaction price of the related revenue arrangements. Modifications We frequently modify contracts to offer customers additional products or services. The additional products and services are generally determined to be distinct from those products or services transferred to the customer before the modification. We evaluate whether the price for the additional products and services reflects the SSP in order to determine the appropriate modification model to apply. If the price reflects SSP, the purchase of additional products and services is accounted for as a separate contract. If the price does not reflect SSP, we account for the modification as the termination of the existing contract and the creation of a new contract. Contract Balances Contract assets consist of unbilled accounts receivable related to goods or services that have been transferred to customers but whose payment is contingent upon future performance. Contract liabilities consist of deferred revenue. Revenue is deferred when we invoice in advance of performance under a contract. Often, certain performance obligations under a contract will be in a contract asset position while other performance obligations under the same contract are in a contract liability position. Contract assets and liabilities pertaining to the same contract are netted in the consolidated balance sheets. Deferred Contract Acquisition Costs We defer sales commissions that are incremental to the acquisition of customer contracts. These costs are recorded as deferred contract acquisition costs on the consolidated balance sheets. We determine whether costs should be deferred based on the terms of our sales compensation and partner incentive plans and whether the commissions are incremental to a customer contract (i.e. would not have occurred absent the customer contract). Under our current sales compensation and certain of our partner incentive plans, commissions for renewals of subscription contracts are not commensurate with the commissions paid on the initial contract. We allocate deferred contract acquisition costs to performance obligations in proportion to the transaction price allocated to each performance obligation and amortize the costs accordingly. Commissions associated with licenses and license renewals are expensed at the time the corresponding licenses revenue is recognized. Commissions associated with subscription services are capitalized and amortized on a straight-line basis over a period of five years for initial contracts, reflecting our estimate of the expected period that we will benefit from those commissions. We determine the period of benefit by taking into consideration the length of our customer contracts, retention rate, the technology lifecycle, and other factors. Commissions paid on renewal contracts that are associated with subscription services are capitalized and amortized over the renewal term. We apply the practical expedient in ASC 340-40, Other Assets and Deferred Costs to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. We periodically review deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded for fiscal years 2024, 2023, or 2022.
Cost of Revenue	Cost of Revenue Licenses Cost of licenses revenue consists of all direct costs to deliver our licenses to customers, amortization of software development costs related to our licenses, and amortization of acquired developed technology. Subscription Services Cost of subscription services revenue consists of personnel-related expenses of our customer support and technical support teams, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of subscription services revenue also includes third-party consulting services, hosting costs related to our SaaS products, amortization of acquired developed technology and capitalized development costs related to SaaS products, and allocated overhead. Overhead is allocated to cost of subscription services revenue based on applicable headcount. We recognize these expenses as they are incurred. Professional Services and Other Cost of professional services and other revenue primarily consists of personnel-related expenses of our professional services team, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of professional services and other revenue also includes subcontracted third-party services and allocated overhead. We recognize these expenses as they are incurred.
Sales and Marketing	Sales and Marketing Sales and marketing expenses consist primarily of personnel-related expenses associated with our sales and marketing employees and related sales support teams, including salaries and bonuses, stock-based compensation expense, employee benefit costs, sales and partner commissions, marketing events, advertising costs, travel, trade shows, other marketing materials, and allocated overhead.
Research and Development	Research and Development Research and development expenses consist primarily of personnel-related expenses, including salaries and bonuses, stock-based compensation expense, and employee benefits costs, for our research and development employees, and allocated overhead. Research and development expenditures are expensed as incurred.
General and Administrative	General and Administrative General and administrative expenses consist primarily of personnel-related expenses, including salaries and bonuses, stock-based compensation expense, and employee benefits costs, associated with our finance, legal, human resources, compliance, and other administrative employees, as well as accounting and legal professional services fees, other corporate-related expenses, and allocated overhead.
Stock-Based Compensation	Stock-Based Compensation We recognize stock-based compensation expense in accordance with the provisions of ASC 718, Compensation—Stock Compensation . ASC 718 requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and non-employees based on the grant date fair value of the awards. The fair value of each stock option is determined using the Black-Scholes pricing model. The fair value of RSUs and RSA is determined based on the fair value of our Class A common stock on the grant date. The fair value of PSUs that are dependent on the satisfaction of a performant condition is also determined based on the fair value of our Class A common stock on the grant date. The fair value of ESPP awards is determined using the Black-Scholes pricing model. Stock-based compensation expense is included in cost of revenue and operating expenses within our consolidated statements of operations based on the expense classification of the individual earning the award. The fair value of awards with only service-based vesting conditions is recognized as expense over the requisite service period on a straight-line basis. For PSUs dependent on the satisfaction of a performance condition, compensation expense is recognized only when management believes it is probable that the performance condition will be achieved. Although total compensation expense recognized for these awards will ultimately equal the grant date fair value per share multiplied by the number of shares earned by the holder, changes in management's expectations can cause fluctuations in timing of expense over the life of these awards. The fair value of ESPP shares is recognized over the relevant offering period on a straight-line basis. With all award types, we account for forfeitures as they occur.
Income Taxes	Income Taxes Pursuant to ASC 740, Income Taxes , we account for income taxes using the asset and liability method, whereby DTAs and DTLs are recognized based on temporary differences between the bases used for financial reporting and income tax reporting purposes. Deferred income taxes are provided based on the enacted tax rates and laws that will be in effect at the time such temporary differences are expected to reverse. A valuation allowance is provided for DTAs if it is more likely than not that we will not realize those tax assets through future operations. ASC 740 prescribes a two-step approach to recognizing and measuring uncertain tax positions: (1) evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any; and (2) measure the tax benefit as the largest amount which is more likely than not of being realized and effectively settled. We consider many factors when evaluating and estimating tax positions and tax benefits, which may require periodic adjustments, and which may not accurately reflect actual outcomes. We recognize any interest and penalties related to uncertain tax positions as a component of provision for (benefit from) income taxes in the consolidated statements of operations.
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders Basic and diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net loss is allocated between Class A and Class B common stock based on the weighted-average shares outstanding for each class. Diluted net loss per share is the same as basic net loss per share because potentially dilutive common stock equivalents are anti-dilutive when in a net loss position. In a period of net income, diluted net income per share would be calculated by giving effect to all potentially dilutive securities outstanding for the period (including unvested RSUs and unexercised stock options under our equity incentive plans, outstanding purchase periods under our ESPP, unvested restricted stock awards and early exercised options subject to repurchase, and returnable common stock issued in connection with business acquisitions) using the treasury stock method. For past periods in which our convertible preferred stock was outstanding, we computed net income or loss per share using the two-class method. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. We considered our convertible preferred stock to be a participating security, as holders had non-forfeitable dividend rights in the event of our declaration of a dividend for shares of common stock. Our convertible preferred stock did not contractually require holders to participate in our losses. As such, net loss for the relevant periods presented was not allocated to our convertible preferred stock. All potentially dilutive common stock equivalents were anti-dilutive in fiscal years 2024, 2023, and 2022, as we were in a net loss position for these periods.
Entity-Wide Information	Entity-Wide Information We operate as one segment. From May 2022 through the end of fiscal year 2024, we operated under a Co-CEO model, with our Co-CEOs acting together as our chief operating decision maker, and allocating resources and assessing performance based upon financial information at the consolidated level.
Variable Interest Entity	Variable Interest Entity When we make an initial investment in or establish other variable interests in an entity, we determine whether that entity is considered a VIE , and, if so, whether we are the primary beneficiary of that VIE. The primary beneficiary of a VIE is a party that meets both of the following criteria: (1) it has the power to direct the activities that most significantly impact the economic performance of the VIE; and (2) it has the obligation to absorb losses or the right to receive benefits that could be potentially significant to the VIE. Periodically, we assess whether any change in our interest in or relationship with the entity affects our determination as to whether the entity is a VIE, and, if so, whether we are the primary beneficiary. We consolidate any VIE of which we are the primary beneficiary. If we are not the primary beneficiary of a VIE, we account for the investment or other variable interests in that VIE in accordance with the applicable accounting guidance.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jan. 31, 2024
Accounting Policies [Abstract]
Schedule of Property and Equipment, Net	Useful lives by asset category are as follows: Asset Category Estimated Useful Life Computer and equipment 1 to 2 years Furniture and fixtures 2 to 9 years Leasehold improvements Shorter of remaining lease term or estimated useful life (1 to 14 years) Property and equipment, net consisted of the following (in thousands): As of January 31, 2024 2023 Computers and equipment $ 23,767 $ 28,450 Leasehold improvements 21,756 19,622 Furniture and fixtures 6,640 6,485 Construction in progress 4,560 2,419 Other 632 — Property and equipment, gross 57,355 56,976 Less: accumulated depreciation (33,373) (27,931) Property and equipment, net $ 23,982 $ 29,045
Schedule of Long-lived Assets by Geographic Region	The following table presents our long-lived assets other than financial instruments, net of accumulated depreciation and amortization, by geographic region (in thousands): As of January 31, 2024 2023 U.S. $ 189,227 $ 212,727 Romania 81,740 74,994 United Kingdom 45,445 47,370 Netherlands 27,004 29,800 Rest of world 29,430 21,466 Total long-lived assets $ 372,846 $ 386,357

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Geographical Region	The following table summarizes revenue by geographical region (dollars in thousands): Year Ended January 31, 2024 2023 2022 Amount Percentage of Amount Percentage of Amount Percentage of Americas (1) $ 631,923 48 % $ 529,060 50 % $ 430,326 48 % Europe, Middle East, and Africa 415,915 32 % 301,036 28 % 261,857 29 % Asia-Pacific (2) 260,234 20 % 228,485 22 % 200,069 23 % Total revenue $ 1,308,072 100 % $ 1,058,581 100 % $ 892,252 100 % (1) Revenue from the U.S. represented 43%, 46%, and 43% of our total revenues for fiscal years 2024, 2023, and 2022, respectively. (2) Revenue from Japan represented 9%, 10%, and 11% of our total revenues for fiscal years 2024, 2023, and 2022, respectively.
Schedule of Significant Changes in Contract Assets and Deferred Revenue	Significant changes in our contract assets and deferred revenue balances during the periods presented were as follows (in thousands): Year Ended January 31, Contract Assets 2024 2023 Beginning balance $ 75,783 $ 77,561 Contract assets recognized during the year 84,180 74,265 Amounts transferred to accounts receivable from unbilled accounts receivable presented at the beginning of the year (69,260) (74,831) Translation adjustments (292) (1,212) Ending balance $ 90,411 $ 75,783 Contract assets, current $ 84,197 $ 69,260 Contract assets, non-current 6,214 6,523 Total contract assets $ 90,411 $ 75,783 Year Ended January 31, Deferred Revenue 2024 2023 Beginning balance $ 520,031 $ 366,020 Additions to deferred revenue during the year 1,364,473 1,145,584 Additions to deferred revenue from business acquisitions — 173 Revenue recognized that was included in deferred revenue at the beginning of the period (398,334) (297,355) Revenue recognized that was not included in deferred revenue at the beginning of the period (828,668) (687,603) Translation adjustments (9,670) (6,788) Ending balance $ 647,832 $ 520,031 Deferred revenue, current $ 486,805 $ 398,334 Deferred revenue, non-current 161,027 121,697 Total deferred revenue $ 647,832 $ 520,031
Rollforward of Deferred Contract Acquisition Costs	The following table represents a rollforward of our deferred contract acquisition costs (in thousands): Year Ended January 31, 2024 2023 Beginning balance $ 187,503 $ 130,150 Additions to deferred contract acquisition costs 118,844 118,909 Amortization of deferred contract acquisition costs (75,471) (59,826) Translation adjustments (1,881) (1,730) Ending balance $ 228,995 $ 187,503 Deferred contract acquisition costs, current $ 74,678 $ 49,887 Deferred contract acquisition costs, non-current 154,317 137,616 Total deferred contract acquisition costs $ 228,995 $ 187,503

Marketable Securities (Tables)

Marketable Securities (Tables)	12 Months Ended
	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	The following is a summary of our marketable securities (in thousands): As of January 31, 2024 Amortized Gross Gross Estimated Treasury bills and U.S government securities 641,263 29 (100) 641,192 Corporate bonds 1,993 — (2) 1,991 Agency bonds 174,990 — (28) 174,962 Total marketable securities $ 818,246 $ 29 $ (130) $ 818,145 As of January 31, 2023 Amortized Gross Gross Estimated Commercial paper $ 62,470 $ — $ — $ 62,470 Treasury bills and U.S government securities (1) $ 234,848 $ — $ (308) $ 234,540 Corporate bonds 46,684 — (198) 46,486 Municipal bonds 6,374 — (66) 6,308 Agency bonds 7,959 — (47) 7,912 Total marketable securities $ 358,335 $ — $ (619) $ 357,716 (1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less.

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	12 Months Ended
	Jan. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables present our financial assets and liabilities measured at fair value on a recurring basis (in thousands): As of January 31, 2024 Level 1 Level 2 Total Financial Assets: Money market funds $ 509,053 $ — $ 509,053 Total cash equivalents 509,053 — 509,053 Treasury bills & U.S. government securities 641,192 — 641,192 Corporate bonds — 1,991 1,991 Agency bonds 174,962 — 174,962 Total marketable securities 816,154 1,991 818,145 Total $ 1,325,207 $ 1,991 $ 1,327,198 As of January 31, 2023 Level 1 Level 2 Total Financial Assets: Money market funds $ 319,801 $ — $ 319,801 Treasury bills 9,968 — 9,968 Total cash equivalents 329,769 — 329,769 Commercial paper — 62,470 62,470 Treasury bills and U.S. government securities 234,540 — 234,540 Corporate bonds — 46,486 46,486 Municipal bonds — 6,308 6,308 Agency bonds 7,912 — 7,912 Total marketable securities 242,452 115,264 357,716 Total $ 572,221 $ 115,264 $ 687,485

Business Acquisitions (Tables)

Business Acquisitions (Tables)	12 Months Ended
	Jan. 31, 2024
Business Combination and Asset Acquisition [Abstract]
Schedule of Total Purchase Consideration	The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following: Cash paid at closing $ 30,117 Fair value of Class A common stock issued at closing (0.2 million shares) 2,965 Loan note paid on first anniversary of closing (July 29, 2023) 5,863 Loan note to be paid on second anniversary of closing (included in accrued expenses and other current liabilities as of January 31, 2024) 5,570 Working capital adjustment 66 Total $ 44,581
Schedule of Fair Values of Assets Acquired and Liabilities Assumed	The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands): July 29, 2022 Net tangible assets $ 300 Intangible assets 13,100 Goodwill 34,351 Total assets acquired 47,751 Deferred tax liabilities assumed (3,170) Total $ 44,581
Schedule of Identifiable Intangible Assets Acquired and Their Estimated Useful Lives	The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Estimated Useful Life Developed technology $ 10,000 5.0 Customer relationships 3,100 3.0 Total $ 13,100

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	12 Months Ended
	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Net	Intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands): Intangible Accumulated Intangible Weighted-Average Developed technology $ 28,807 $ (16,881) $ 11,926 2.8 Customer relationships 8,266 (6,306) 1,960 1.3 Trade names and trademarks 272 (266) 6 0.2 Other intangibles 1,231 (419) 812 7.0 Total $ 38,576 $ (23,872) $ 14,704 Intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands): Intangible Accumulated Intangible Weighted-Average Developed technology $ 28,517 $ (11,095) $ 17,422 3.5 Customer relationships 8,174 (3,601) 4,573 2.0 Trade names and trademarks 272 (233) 39 1.2 Other intangibles 1,231 (255) 976 7.7 Total $ 38,194 $ (15,184) $ 23,010
Schedule of Expected Future Amortization Expenses Related to Intangible Assets	Expected future amortization expense related to intangible assets was as follows as of January 31, 2024 (in thousands): Year Ended January 31, Amount 2025 $ 6,684 2026 4,105 2027 2,448 2028 1,163 2029 101 Thereafter 203 Total $ 14,704
Schedule of Changes in Carrying Amounts of Goodwill	Changes in the carrying amount of goodwill were as follows during the periods presented (in thousands): Carrying Amount Balance as of January 31, 2022 $ 53,564 Acquisition of Re:infer 34,351 Effect of foreign currency translation 95 Balance as of January 31, 2023 88,010 Effect of foreign currency translation 1,016 Balance as of January 31, 2024 $ 89,026

Operating Leases (Tables)

Operating Leases (Tables)	12 Months Ended
	Jan. 31, 2024
Leases [Abstract]
Schedule of Lease Costs and Supplemental Cash Flow Information	Lease costs are presented below (in thousands): Year Ended January 31, 2024 2023 2022 Operating lease cost $ 13,047 $ 11,675 $ 8,875 Short-term lease cost 4,965 5,895 4,387 Variable lease cost 2,142 1,418 582 Sublease income (1) (1,615) (2,129) (355) Total lease cost $ 18,539 $ 16,859 $ 13,489 (1) Included in other income (expense), net in the consolidated statements of operations Supplemental cash flow information related to operating leases is as follows for the periods presented (in thousands): Year Ended January 31, 2024 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 12,907 $ 6,702 $ 9,358 Operating lease ROU assets obtained in exchange for new operating lease liabilities $ 12,986 $ 11,511 $ 35,262
Schedule of Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases is as follows (in thousands): As of January 31, 2024 2023 Assets: Operating lease right-of-use assets $ 56,072 $ 52,052 Liabilities: Operating lease liabilities, current (included in accrued expenses and other current liabilities) $ 8,357 $ 6,997 Operating lease liabilities, non-current 58,713 56,442 Total operating lease liabilities $ 67,070 $ 63,439
Schedule of Weighted-average Remaining Lease Term and Discount Rate	The following table represents the weighted-average remaining lease term and discount rate for the periods presented: As of January 31, 2024 2023 Weighted-average remaining lease term (years) 10.7 12.1 Weighted-average discount rate 7.1 % 7.0 %
Schedule of Future Undiscounted Lease Payments for Operating Lease Liabilities	Future undiscounted lease payments for our operating lease liabilities as of January 31, 2024 were as follows (in thousands): Amount Year Ended January 31, 2025 $ 12,719 2026 11,838 2027 10,666 2028 9,012 2029 5,752 Thereafter 44,190 Total operating lease payments 94,177 Less: imputed interest (27,107) Total operating lease liabilities $ 67,070

Consolidated Balance Sheet Co_2

Consolidated Balance Sheet Components (Tables)	12 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): As of January 31, 2024 2023 Prepaid expenses and service credits $ 87,781 $ 67,794 Other current assets 17,199 26,356 Prepaid expenses and other current assets $ 104,980 $ 94,150
Schedule of Property and Equipment, Net	Useful lives by asset category are as follows: Asset Category Estimated Useful Life Computer and equipment 1 to 2 years Furniture and fixtures 2 to 9 years Leasehold improvements Shorter of remaining lease term or estimated useful life (1 to 14 years) Property and equipment, net consisted of the following (in thousands): As of January 31, 2024 2023 Computers and equipment $ 23,767 $ 28,450 Leasehold improvements 21,756 19,622 Furniture and fixtures 6,640 6,485 Construction in progress 4,560 2,419 Other 632 — Property and equipment, gross 57,355 56,976 Less: accumulated depreciation (33,373) (27,931) Property and equipment, net $ 23,982 $ 29,045
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of January 31, 2024 2023 Accrued expenses $ 18,458 $ 19,411 Withholding tax from employee equity transactions 3,277 3,772 Employee stock purchase plan withholdings 3,618 3,365 Payroll taxes and other benefits payable 3,888 7,644 Income tax payable 7,140 8,750 Value-added taxes payable 6,480 6,381 Operating lease liabilities, current 8,357 6,997 Deferred consideration for business acquisition, current 5,570 5,863 Rebates payable to partners 7,289 — Other 19,920 14,462 Accrued expenses and other current liabilities $ 83,997 $ 76,645

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Accrued Restructuring Costs	The following table shows the total amount incurred during fiscal years 2024 and 2023, and the related liability, which is recorded in accrued compensation and employee benefits in the consolidated balance sheets, for restructuring-related costs (in thousands): Accrued restructuring costs as of January 31, 2022 $ — Restructuring costs incurred during fiscal year 2023 $ 23,446 Amount paid during fiscal year 2023 $ (19,339) Write-off of assets associated with Brooklyn office $ (218) Accrued restructuring costs as of January 31, 2023 $ 3,889 Restructuring costs incurred during fiscal year 2024 2,626 Amount paid during fiscal year 2024 (6,180) Accrued restructuring costs as of January 31, 2024 $ 335
Schedule of Restructuring Costs	The following table presents the restructuring charges incurred (in thousands): Year Ended January 31, 2024 2023 Employee Termination Benefits Lease Exit Costs Total Restructuring Costs Employee Termination Benefits Lease Exit Costs Total Restructuring Costs Cost of subscription services revenue $ 114 $ — $ 114 $ 76 $ 106 $ 182 Cost of professional services and other revenue — — — 585 125 710 Sales and marketing 1,376 — 1,376 18,965 526 19,491 Research and development 387 — 387 448 46 494 General and administrative 749 — 749 2,192 377 2,569 Total $ 2,626 $ — $ 2,626 $ 22,266 $ 1,180 $ 23,446
Schedule of Non-cancelable Purchase Obligations	As of January 31, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Year Ended January 31, Amount 2025 $ 68,958 2026 70,597 2027 23,092 2028 8,450 2029 18 Thereafter — Total $ 171,115

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Jan. 31, 2024
Equity [Abstract]
Schedule of Changes In Components of Accumulated Other Comprehensive Income (Loss)	Changes in the components of accumulated other comprehensive income (loss) were as follows during the periods presented (in thousands): Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2022 $ 11,234 $ (335) $ 10,899 Other comprehensive loss, net of tax (3,003) (284) (3,287) Balance as of January 31, 2023 $ 8,231 $ (619) $ 7,612 Other comprehensive income, net of tax 694 519 1,213 Balance as of January 31, 2024 $ 8,925 $ (100) $ 8,825

Equity Incentive Plans and St_2

Equity Incentive Plans and Stock-Based Compensation (Tables)	12 Months Ended
	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Option Activity Under Stock Plans	Stock option activity during fiscal year 2024 was as follows: Options Outstanding Stock Options (in thousands) Weighted-Average Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Balance as of January 31, 2023 13,898 $ 3.32 7.7 $ 169,324 Granted 2,995 $ 0.10 Exercised (5,221) $ 1.29 Forfeited (592) $ 1.80 Expired — $ — Balance as of January 31, 2024 11,080 $ 3.49 7.8 $ 216,010 Vested and exercisable as of January 31, 2024 4,990 $ 4.59 6.6 $ 91,793
Schedule of Fair Value Assumptions for Stock Options	Fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions: Year Ended January 31, 2024 2023 2022 Expected term (years) 5.9 5.9 6.1 Expected volatility 65.2% 60.6% 57.2% Risk-free interest rate 3.6% 3.5% 1.4% Expected dividend yield 0.0% 0.0% 0.0%
Summary of RSU Activity	RSU activity during fiscal year 2024 was as follows: RSUs (in thousands) Weighted-Average Grant Unvested as of January 31, 2023 36,785 $ 22.48 Granted 19,274 $ 16.95 Vested (17,556) $ 20.64 Forfeited (7,231) $ 23.39 Unvested as of January 31, 2024 31,272 $ 19.89
Schedule of Fair Value Assumptions for ESPP Shares	The fair value of ESPP awards was estimated using the Black-Scholes option pricing model with the following weighted-average assumptions: Year Ended January 31, 2024 2023 2022 Expected term (years) 0.5 0.5 0.6 Expected volatility 67.4% 69.0% 55.7% Risk-free interest rate 5.02% 1.86% 0.05% Expected dividend yield 0.0% 0.0% 0.0%
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense is classified in the consolidated statements of operations as follows (in thousands): Year Ended January 31, 2024 2023 2022 (1) Cost of subscription services revenue $ 14,750 $ 11,894 $ 12,232 Cost of professional services and other revenue 10,958 11,855 29,849 Sales and marketing 144,863 154,922 237,975 Research and development 117,965 102,546 135,713 General and administrative 83,419 88,623 99,814 Total $ 371,955 $ 369,840 $ 515,583 (1) Presented net of capitalized stock-based compensation relating to software development costs of $4.5 million.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Domestic and Foreign Components of Loss before Income Taxes	The U.S. and foreign components o f loss before income taxes are as follows for the periods presented (in thousands): Year Ended January 31, 2024 2023 2022 U.S. $ (168,587) $ (273,467) $ (306,814) Foreign 92,772 (44,094) (204,069) Loss before income taxes $ (75,815) $ (317,561) $ (510,883)
Schedule of Components of the Provision for Income Taxes	The components of the provision for income taxes are as follows for the periods presented (in thousands): Year Ended January 31, 2024 2023 2022 Current expense (benefit) Federal $ (106) $ 213 $ — State (166) 493 80 Foreign 13,786 9,224 20,455 Total current expense 13,514 9,930 20,535 Deferred expense (benefit) Federal — — — State — — — Foreign 554 861 (5,832) Total deferred expense (benefit) $ 554 $ 861 $ (5,832) Total provision for income taxes $ 14,068 $ 10,791 $ 14,703
Reconciliation of Statutory Federal Income Tax Rate to Effective Income Tax Rate	The following is a reconciliation of the statutory federal income tax rate to our effective tax rate for the periods presented: Year Ended January 31, 2024 2023 2022 Federal statutory income tax rate 21.0 % 21.0 % 21.0 % Foreign taxes (2.0) (2.2) (3.7) Non-deductible expenses (17.9) (2.1) (2.7) Stock-based compensation (4.6) (10.8) 27.1 Valuation allowance (5.7) (12.3) (48.2) Research and development credits 18.9 3.3 3.8 Cross border tax law (27.4) — — Other, net (0.9) (0.3) (0.2) Effective income tax rate (18.6) % (3.4) % (2.9) %
Schedule of DTAs and DTLs	Significant components of DTAs and DTLs are as follows as of the periods presented (in thousands): As of January 31, 2024 2023 Deferred tax assets: Net operating loss carryforwards $ 344,067 $ 387,822 Accruals and reserves 15,823 15,072 Stock-based compensation 11,888 25,665 Deferred revenue 25,942 9,477 Research and development 103,263 67,103 Depreciation and amortization 587 587 Excessive borrowing — 1,668 Lease liabilities (1) 11,563 — Other (1) 5,602 7,406 Total deferred tax assets, gross 518,735 514,800 Less: valuation allowance (470,040) (476,589) Total deferred tax assets, net of valuation allowance 48,695 38,211 Deferred tax liabilities: Intangible assets (2,409) (3,312) Foreign exchange (37) (97) Right-of-use assets (1) (8,957) — Commissions (32,747) (29,245) Total deferred tax liabilities (44,150) (32,654) Net deferred tax assets $ 4,545 $ 5,557 Net deferred tax assets $ 4,678 $ 5,895 Net deferred tax liabilities (included in other liabilities, non-current) (133) (338) Net deferred tax assets $ 4,545 $ 5,557 (1) As of January 31, 2023, immaterial amounts related to lease liabilities and right-of-use assets and were presented as part of "Other."
Schedule of Activity of the DTA Valuation Allowance	The table below details the changes in DTA valuation allowances for the periods presented (in thousands): Beginning Additions During the Period Reductions During the Period Ending Year ended January 31, 2024 $ 476,589 $ 5,474 $ (12,023) $ 470,040 Year ended January 31, 2023 $ 422,262 $ 54,327 $ — $ 476,589

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	12 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts): Year Ended January 31, 2024 2023 2022 Class A Class B Class A Class B Class A Class B Numerator: Net loss $ (76,739) $ (13,144) $ (278,950) $ (49,402) $ (423,296) $ (102,290) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 481,402 82,453 465,569 82,453 366,146 88,479 Net loss per share attributable to common stockholders, basic and diluted $ (0.16) $ (0.16) $ (0.60) $ (0.60) $ (1.16) $ (1.16)
Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share	Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands): Year Ended January 31, 2024 2023 2022 Class A Class B Class A Class B Class A Class B Convertible preferred stock — — — — 68,015 — Unvested RSUs 36,878 — 31,427 — 23,237 — Outstanding stock options 13,247 — 13,967 — 18,424 — Shares subject to repurchase from RSAs and early exercised stock options 52 — 284 — 1,539 — Shares issuable under ESPP 705 — 828 — 312 — Returnable shares issued in connection with business acquisition 349 — 219 — — — Total 51,231 — 46,725 — 111,527 —

Organization and Description _2

Organization and Description of Business (Details)	Jan. 31, 2024 country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries having legal presence	32

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details)	12 Months Ended
	Jan. 31, 2024 USD ($) segment	Jan. 31, 2023 USD ($)	Jan. 31, 2022 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gains (losses)	$ 300,000	$ (500,000)	$ (17,200,000)
Available for sale marketable securities, allowance for credit loss	0	0
Debt securities, impairments	0	0	0
Allowance for credit losses	1,119,000	2,698,000
Credit loss expense	(1,600,000)	1,200,000	700,000
Capitalized costs for cloud computing arrangements, gross	2,700,000	2,200,000
Capitalized costs for cloud computing arrangements, amortization expense	0	1,000,000	900,000
Capitalized costs for cloud computing arrangements, accumulated amortization	2,200,000	2,200,000
Gross license fees paid	4,200,000	22,400,000
License fees, amortization expense	8,400,000	7,300,000	7,500,000
License fees, accumulated amortization expense	0	17,600,000
Impairment charges to goodwill	$ 0	0	0
Deferred contract acquisition costs, amortization period	5 years
Impairment loss on deferred contract acquisition costs	$ 0	0	0
Advertising costs	$ 44,300,000	41,500,000	43,300,000
Number of operating segments | segment	1
Minimum
Summary Of Significant Accounting Policies [Line Items]
Receivable, payment term	30 days
Maximum
Summary Of Significant Accounting Policies [Line Items]
Receivable, payment term	60 days
SaaS Product Development
Summary Of Significant Accounting Policies [Line Items]
Capitalized software, estimated useful life	5 years
Capitalized software development costs, gross	$ 7,500,000	7,500,000
Capitalized software development costs, amortization expense	1,300,000	1,300,000	1,200,000
Capitalized software development costs, accumulated amortization	$ 4,300,000	3,000,000
Software Development
Summary Of Significant Accounting Policies [Line Items]
Capitalized software, estimated useful life	5 years
Capitalized software development costs, gross	$ 4,200,000	4,300,000
Capitalized software development costs, amortization expense	900,000	900,000	700,000
Capitalized software development costs, accumulated amortization	$ 3,000,000	$ 2,100,000
Geographic Concentration Risk | Cash and cash equivalents | United States, European Union (“EU”) Countries, and Japan
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	91%	98%
Foreign Currency Forward Contracts
Summary Of Significant Accounting Policies [Line Items]
Net gains (losses) associated with foreign currency forward contracts			$ 8,300,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Property and Equipment Useful Lives (Details)	Jan. 31, 2024
Computers and equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	1 year
Computers and equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	2 years
Furniture and fixtures | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	2 years
Furniture and fixtures | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	9 years
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	1 year
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	14 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Long-Lived Assets by Geographic Region (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	$ 372,846	$ 386,357
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	189,227	212,727
Romania
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	81,740	74,994
United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	45,445	47,370
Netherlands
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	27,004	29,800
Rest of world
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	$ 29,430	$ 21,466

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue by Region According to Location of Customers (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,308,072	$ 1,058,581	$ 892,252
Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100%	100%	100%
Americas
Disaggregation of Revenue [Line Items]
Total revenue	$ 631,923	$ 529,060	$ 430,326
Americas | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	48%	50%	48%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Total revenue	$ 415,915	$ 301,036	$ 261,857
Europe, Middle East, and Africa | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	32%	28%	29%
Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 260,234	$ 228,485	$ 200,069
Asia-Pacific | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	20%	22%	23%
U.S. | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	43%	46%	43%
Japan | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	9%	10%	11%

Revenue Recognition - Significa

Revenue Recognition - Significant Changes in Contract Assets and Deferred Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Contract Assets
Beginning balance	$ 75,783	$ 77,561
Contract assets recognized during the year	84,180	74,265
Amounts transferred to accounts receivable from unbilled accounts receivable presented at the beginning of the year	(69,260)	(74,831)
Translation adjustments	(292)	(1,212)
Ending balance	90,411	75,783
Contract assets, current	84,197	69,260
Contract assets, non-current	6,214	6,523
Total contract assets	90,411	75,783
Deferred Revenue
Beginning balance	520,031	366,020
Additions to deferred revenue during the year	1,364,473	1,145,584
Additions to deferred revenue from business acquisitions	0	173
Revenue recognized that was included in deferred revenue at the beginning of the period	(398,334)	(297,355)
Revenue recognized that was not included in deferred revenue at the beginning of the period	(828,668)	(687,603)
Translation adjustments	(9,670)	(6,788)
Ending balance	647,832	520,031
Deferred revenue, current	486,805	398,334
Deferred revenue, non-current	161,027	121,697
Total deferred revenue	$ 647,832	$ 520,031

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligations (Details) $ in Millions	Jan. 31, 2024 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 1,159.9
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	647.8
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 512.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-02-01
Disaggregation of Revenue [Line Items]
Remaining performance obligations, percentage	61%
Remaining performance obligations, period	12 months

Revenue Recognition - Rollforwa

Revenue Recognition - Rollforward of Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Deferred Contract Acquisition Costs
Beginning balance	$ 187,503	$ 130,150
Additions to deferred contract acquisition costs	118,844	118,909
Amortization of deferred contract acquisition costs	(75,471)	(59,826)	$ (39,257)
Translation adjustments	(1,881)	(1,730)
Ending balance	228,995	187,503	130,150
Deferred contract acquisition costs, current	74,678	49,887
Deferred contract acquisition costs, non-current	154,317	137,616
Total deferred contract acquisition costs	$ 228,995	$ 187,503	$ 130,150

Marketable Securities - Schedul

Marketable Securities - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 818,246	$ 358,335
Gross Unrealized Gains	29	0
Gross Unrealized Losses	(130)	(619)
Estimated Fair Value	818,145	357,716
Cash and cash equivalents, amortized cost	1,061,678	1,402,119
Treasury bills & U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	641,263	234,848
Gross Unrealized Gains	29	0
Gross Unrealized Losses	(100)	(308)
Estimated Fair Value	641,192	234,540
Treasury bills
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents, amortized cost		10,000
Cash and cash equivalents, fair value		10,000
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		62,470
Gross Unrealized Gains		0
Gross Unrealized Losses		0
Estimated Fair Value		62,470
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,993	46,684
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(2)	(198)
Estimated Fair Value	1,991	46,486
Municipal bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		6,374
Gross Unrealized Gains		0
Gross Unrealized Losses		(66)
Estimated Fair Value		6,308
Agency bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	174,990	7,959
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(28)	(47)
Estimated Fair Value	$ 174,962	$ 7,912

Marketable Securities - Additio

Marketable Securities - Additional Information (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable securities with contractual maturities of one year or more	$ 0	$ 2,942
Interest receivable	$ 3,300	$ 3,500

Fair Value Measurement (Details

Fair Value Measurement (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Financial Assets:
Total marketable securities	$ 818,145	$ 357,716
Treasury bills
Financial Assets:
Total cash equivalents		10,000
Commercial paper
Financial Assets:
Total marketable securities		62,470
Treasury bills & U.S. government securities
Financial Assets:
Total marketable securities	641,192	234,540
Corporate bonds
Financial Assets:
Total marketable securities	1,991	46,486
Municipal bonds
Financial Assets:
Total marketable securities		6,308
Agency bonds
Financial Assets:
Total marketable securities	174,962	7,912
Recurring
Financial Assets:
Total cash equivalents	509,053	329,769
Total marketable securities	818,145	357,716
Total	1,327,198	687,485
Recurring | Money market funds
Financial Assets:
Total cash equivalents	509,053	319,801
Recurring | Treasury bills
Financial Assets:
Total cash equivalents		9,968
Recurring | Commercial paper
Financial Assets:
Total marketable securities		62,470
Recurring | Treasury bills & U.S. government securities
Financial Assets:
Total marketable securities	641,192	234,540
Recurring | Corporate bonds
Financial Assets:
Total marketable securities	1,991	46,486
Recurring | Municipal bonds
Financial Assets:
Total marketable securities		6,308
Recurring | Agency bonds
Financial Assets:
Total marketable securities	174,962	7,912
Recurring | Level 1
Financial Assets:
Total cash equivalents	509,053	329,769
Total marketable securities	816,154	242,452
Total	1,325,207	572,221
Recurring | Level 1 | Money market funds
Financial Assets:
Total cash equivalents	509,053	319,801
Recurring | Level 1 | Treasury bills
Financial Assets:
Total cash equivalents		9,968
Recurring | Level 1 | Commercial paper
Financial Assets:
Total marketable securities		0
Recurring | Level 1 | Treasury bills & U.S. government securities
Financial Assets:
Total marketable securities	641,192	234,540
Recurring | Level 1 | Corporate bonds
Financial Assets:
Total marketable securities	0	0
Recurring | Level 1 | Municipal bonds
Financial Assets:
Total marketable securities		0
Recurring | Level 1 | Agency bonds
Financial Assets:
Total marketable securities	174,962	7,912
Recurring | Level 2
Financial Assets:
Total cash equivalents	0	0
Total marketable securities	1,991	115,264
Total	1,991	115,264
Recurring | Level 2 | Money market funds
Financial Assets:
Total cash equivalents	0	0
Recurring | Level 2 | Treasury bills
Financial Assets:
Total cash equivalents		0
Recurring | Level 2 | Commercial paper
Financial Assets:
Total marketable securities		62,470
Recurring | Level 2 | Treasury bills & U.S. government securities
Financial Assets:
Total marketable securities	0	0
Recurring | Level 2 | Corporate bonds
Financial Assets:
Total marketable securities	1,991	46,486
Recurring | Level 2 | Municipal bonds
Financial Assets:
Total marketable securities		6,308
Recurring | Level 2 | Agency bonds
Financial Assets:
Total marketable securities	0	0
Recurring | Level 3
Financial Assets:
Total	$ 0	$ 0

Business Acquisitions - Schedul

Business Acquisitions - Schedule of Total Purchase Consideration (Details) - USD ($) $ in Thousands, shares in Millions		12 Months Ended
	Jul. 29, 2022	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Business Acquisition [Line Items]
Deferred consideration		$ 0	$ 11,433	$ 0
Re:infer
Business Acquisition [Line Items]
Cash paid at closing	$ 30,117
Fair value of Class A common stock issued at closing	2,965
Working capital adjustment	66
Total consideration	$ 44,581
Stock issued at closing (in shares)	0.2
Re:infer | First Anniversary of Closing
Business Acquisition [Line Items]
Deferred consideration	$ 5,863
Re:infer | Second Anniversary of Closing
Business Acquisition [Line Items]
Deferred consideration	$ 5,570

Business Acquisitions - Additio

Business Acquisitions - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions		12 Months Ended
	Jul. 29, 2022	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Business Acquisition [Line Items]
Provisional purchase price allocation to goodwill		$ 89,026	$ 88,010	$ 53,564
Re:infer
Business Acquisition [Line Items]
Total purchase consideration	$ 44,581
Stock issued at closing subject to clawback provisions (in shares)	0.4
Weighted-average remaining period		1 year 6 months
Provisional purchase price allocation to goodwill	$ 34,351
Goodwill, deductible for tax purposes	0
Purchase price allocation to goodwill			$ 1,100
Re:infer | Common stock
Business Acquisition [Line Items]
Unrecognized compensation expense	$ 7,600
Weighted-average remaining period	3 years

Business Acquisitions - Sched_2

Business Acquisitions - Schedule of Fair Values of Assets Acquired and Liabilities Assumed, re: Infer (Details) - USD ($) $ in Thousands	Jul. 29, 2022	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Business Acquisition [Line Items]
Goodwill		$ 89,026	$ 88,010	$ 53,564
Re:infer
Business Acquisition [Line Items]
Net tangible assets	$ 300
Intangible assets	13,100
Goodwill	34,351
Total assets acquired	47,751
Deferred tax liabilities assumed	(3,170)
Total consideration	$ 44,581

Business Acquisitions - Sched_3

Business Acquisitions - Schedule of Identifiable Intangible Assets Acquired and Their Estimated Useful Lives (Details) - Re:infer $ in Thousands	Jul. 29, 2022 USD ($)
Business Acquisition [Line Items]
Fair Value	$ 13,100
Developed technology
Business Acquisition [Line Items]
Fair Value	$ 10,000
Estimated Useful Life	5 years
Customer relationships
Business Acquisition [Line Items]
Fair Value	$ 3,100
Estimated Useful Life	3 years

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 38,576	$ 38,194
Accumulated Amortization	(23,872)	(15,184)
Intangible Assets, Net	14,704	23,010
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	28,807	28,517
Accumulated Amortization	(16,881)	(11,095)
Intangible Assets, Net	$ 11,926	$ 17,422
Weighted-Average Remaining Useful Life (Years)	2 years 9 months 18 days	3 years 6 months
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 8,266	$ 8,174
Accumulated Amortization	(6,306)	(3,601)
Intangible Assets, Net	$ 1,960	$ 4,573
Weighted-Average Remaining Useful Life (Years)	1 year 3 months 18 days	2 years
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 272	$ 272
Accumulated Amortization	(266)	(233)
Intangible Assets, Net	$ 6	$ 39
Weighted-Average Remaining Useful Life (Years)	2 months 12 days	1 year 2 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 1,231	$ 1,231
Accumulated Amortization	(419)	(255)
Intangible Assets, Net	$ 812	$ 976
Weighted-Average Remaining Useful Life (Years)	7 years	7 years 8 months 12 days

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense of acquired intangible assets	$ 8.6	$ 6.9	$ 5.1

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Schedule of Expected Future Amortization Expenses Related to Intangible Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 6,684
2026	4,105
2027	2,448
2028	1,163
2029	101
Thereafter	203
Intangible Assets, Net	$ 14,704	$ 23,010

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Goodwill [Roll Forward]
Beginning balance	$ 88,010	$ 53,564
Acquisition of Re:infer		34,351
Effect of foreign currency translation	1,016	95
Ending balance	$ 89,026	$ 88,010

Operating Leases - Additional I

Operating Leases - Additional Information (Details) $ in Millions	Jan. 31, 2024 USD ($)
Lessee, Lease, Description [Line Items]
Non-cancellable commitments for operating leases that have not yet commenced	$ 32.7
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, remaining lease term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, remaining lease term	14 years

Operating Leases - Summary of L

Operating Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Leases [Abstract]
Operating lease cost	$ 13,047	$ 11,675	$ 8,875
Short-term lease cost	4,965	5,895	4,387
Variable lease cost	2,142	1,418	582
Sublease income	(1,615)	(2,129)	(355)
Total lease cost	$ 18,539	$ 16,859	$ 13,489

Operating Leases - Supplemental

Operating Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Assets:
Operating lease right-of-use assets	$ 56,072	$ 52,052
Liabilities:
Operating lease liabilities, current (included in accrued expenses and other current liabilities)	8,357	6,997
Operating lease liabilities, non-current	58,713	56,442
Total operating lease liabilities	$ 67,070	$ 63,439
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities

Operating Leases - Supplement_2

Operating Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 12,907	$ 6,702	$ 9,358
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 12,986	$ 11,511	$ 35,262

Operating Leases - Weighted Ave

Operating Leases - Weighted Average Lease Term and Discount Rate Related to Operating Lease Right-of-Use Assets and Lease Liabilities (Details)	Jan. 31, 2024	Jan. 31, 2023
Leases [Abstract]
Weighted-average remaining lease term (years)	10 years 8 months 12 days	12 years 1 month 6 days
Weighted-average discount rate	7.10%	7%

Operating Leases - Summary of F

Operating Leases - Summary of Future Undiscounted Lease Payments for Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Leases [Abstract]
2025	$ 12,719
2026	11,838
2027	10,666
2028	9,012
2029	5,752
Thereafter	44,190
Total operating lease payments	94,177
Less: imputed interest	(27,107)
Total operating lease liabilities	$ 67,070	$ 63,439

Consolidated Balance Sheet Co_3

Consolidated Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses and service credits	$ 87,781	$ 67,794
Other current assets	17,199	26,356
Prepaid expenses and other current assets	$ 104,980	$ 94,150

Consolidated Balance Sheet Co_4

Consolidated Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 57,355	$ 56,976
Less: accumulated depreciation	(33,373)	(27,931)
Property and equipment, net	23,982	29,045
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	23,767	28,450
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	21,756	19,622
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,640	6,485
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	4,560	2,419
Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 632	$ 0

Consolidated Balance Sheet Co_5

Consolidated Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 11.1	$ 8.6	$ 6.8

Consolidated Balance Sheet Co_6

Consolidated Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 18,458	$ 19,411
Withholding tax from employee equity transactions	3,277	3,772
Employee stock purchase plan withholdings	3,618	3,365
Payroll taxes and other benefits payable	3,888	7,644
Income tax payable	7,140	8,750
Value-added taxes payable	6,480	6,381
Operating lease liabilities, current	8,357	6,997
Deferred consideration for business acquisition, current	5,570	5,863
Rebates payable to partners	7,289	0
Other	19,920	14,462
Accrued expenses and other current liabilities	$ 83,997	$ 76,645

Credit Facility (Details)

Credit Facility (Details)	Oct. 30, 2020 USD ($)
HSBC Ventures USA Inc., Silicon Valley Bank, Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD | Senior Secured Credit Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity under credit agreement	$ 200,000,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022	Nov. 10, 2022	Jun. 24, 2022
Loss Contingencies [Line Items]
Letters of credit outstanding	$ 2,600	$ 4,300
Expected percentage reduction of global workforce				6%	5%
Restructuring costs incurred	2,626	23,446
Defined contribution plan cost	16,000	$ 14,500	$ 10,400
Litigation Matters
Loss Contingencies [Line Items]
Loss contingency accrual	0
Product Liability Contingencies
Loss Contingencies [Line Items]
Loss contingency accrual	0
Other Matters
Loss Contingencies [Line Items]
Loss contingency accrual	$ 0

Commitments and Contingencies_2

Commitments and Contingencies - Accrued Restructuring Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Restructuring Reserve [Roll Forward]
Accrued restructuring costs, beginning balance	$ 3,889	$ 0
Restructuring costs incurred	2,626	23,446
Amount paid	(6,180)	(19,339)
Write-off of assets associated with Brooklyn office		(218)
Accrued restructuring costs, ending balance	$ 335	$ 3,889

Commitments and Contingencies_3

Commitments and Contingencies - Restructuring Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 2,626	$ 23,446
Cost of revenue | Subscription services
Restructuring Cost and Reserve [Line Items]
Restructuring charges	114	182
Cost of revenue | Professional services and other
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	710
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1,376	19,491
Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring charges	387	494
General and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring charges	749	2,569
Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2,626	22,266
Employee Termination Benefits | Cost of revenue | Subscription services
Restructuring Cost and Reserve [Line Items]
Restructuring charges	114	76
Employee Termination Benefits | Cost of revenue | Professional services and other
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	585
Employee Termination Benefits | Sales and marketing
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1,376	18,965
Employee Termination Benefits | Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring charges	387	448
Employee Termination Benefits | General and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring charges	749	2,192
Lease Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	1,180
Lease Exit Costs | Cost of revenue | Subscription services
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	106
Lease Exit Costs | Cost of revenue | Professional services and other
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	125
Lease Exit Costs | Sales and marketing
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	526
Lease Exit Costs | Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	46
Lease Exit Costs | General and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0	$ 377

Commitments and Contingencies_4

Commitments and Contingencies - Schedule of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Jan. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2025	$ 68,958
2026	70,597
2027	23,092
2028	8,450
2029	18
Thereafter	0
Total	$ 171,115

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) $ / shares in Units, shares in Thousands	1 Months Ended		12 Months Ended
	Mar. 12, 2024 $ / shares shares	Apr. 30, 2021 vote shares	Jan. 31, 2024 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) shares	Jan. 31, 2022 USD ($)	Sep. 01, 2023 USD ($)
Class of Stock [Line Items]
Common stock, conversion ratio		1
Period for conversion of common stock B into common stock A subsequent to death or incapacity of the Chief Executive Officer		6 months
Charitable donation of Class A common stock | $			$ 4,215,000	$ 5,499,000	$ 0
Preferred stock, shares authorized (in shares)		20,000	20,000	20,000
Minimum
Class of Stock [Line Items]
Number of days fixed for conversion of common stock B into common stock A immediately prior to completion of IPO		120 days
Maximum
Class of Stock [Line Items]
Number of days fixed for conversion of common stock B into common stock A immediately prior to completion of IPO		180 days
Percentage of outstanding shares of common stock required for automatic conversion following date fixed for conversion		20%
Class A Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		2,000,000	2,000,000	2,000,000
Common stock, voting rights, votes per share | vote		1
Class A Common Stock | Common stock
Class of Stock [Line Items]
Repurchase authorized | $						$ 500,000,000
Repurchase of Class A common stock (in shares)			5,800
Average price of common shares (in dollar per share) | $ / shares			$ 17.57
Common stock shares reserved to fund social impact and environmental, social and governance initiatives (in shares)			2,800
Charitable donation of Class A common stock (in shares)			281	300
Class A Common Stock | Common stock | Subsequent Event
Class of Stock [Line Items]
Repurchase of Class A common stock (in shares)	900
Average price of common shares (in dollar per share) | $ / shares	$ 23.46
Class B Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		115,700	115,741	115,741
Common stock, voting rights, votes per share | vote		35

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Changes in Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 1,920,158	$ 1,921,917	$ (803,704)
Other comprehensive income (loss), net of tax	1,213	(3,287)	23,420
Ending balance	2,016,114	1,920,158	1,921,917
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	7,612	10,899	(12,521)
Other comprehensive income (loss), net of tax	1,213	(3,287)	23,420
Ending balance	8,825	7,612	10,899
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	8,231	11,234
Other comprehensive income (loss), net of tax	694	(3,003)
Ending balance	8,925	8,231	11,234
Unrealized Gain (Loss) on Marketable Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(619)	(335)
Other comprehensive income (loss), net of tax	519	(284)
Ending balance	$ (100)	$ (619)	$ (335)

Equity Incentive Plans and St_3

Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended			12 Months Ended
	Jul. 29, 2022	Apr. 23, 2021	Jul. 31, 2023	Apr. 22, 2021	Jun. 30, 2018	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022	Apr. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested options expiration period after termination of employment						3 months
Weighted-average grant date fair value of stock options granted (in dollars per share)						$ 16.84	$ 12.23	$ 45.78
Intrinsic value of stock options exercised						$ 93,200	$ 83,600	$ 557,500
Cost not yet recognized for unvested options						102,500
Repurchase of unvested early exercised stock options						0	1,493	0
Stock-based compensation expense						$ 371,955	$ 369,840	$ 515,583
Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period						1 year 6 months
Unrecognized compensation expense						$ 3,800
Stock issued at closing subject to clawback provisions (in shares)	400,000
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)				15,500,000
Period of shares automatically increase				10 years
Percentage of total number of shares				1%
Number of shares authorized (in shares)						21,500,000
Weighted-average remaining period						4 months 24 days
Unrecognized compensation expense						$ 3,000
Shares purchased (in shares)						1,400,000
Public offering price per share (in dollars per share)						$ 12.69
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award expiration period						10 years
Weighted-average remaining period						2 years 1 month 6 days
Accelerated vesting shares (in shares)							300,000	200,000
Incremental expense							$ 2,800	$ 2,900
Stock Options | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period						3 years
Stock Options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period						4 years
Early Exercised Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Repurchase of unvested early exercised stock options							$ 1,500
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period						2 years 3 months 18 days
Accelerated vesting shares (in shares)							500,000	200,000
Incremental expense								$ 10,900
Fair value of RSUs vested						$ 329,600	$ 228,800	$ 1,400,000
Unrecognized compensation expense						$ 560,500
Net reduction in fair value of modified awards							$ (7,400)
Granted (in shares)						19,274,000
Granted (in dollars per share)						$ 16.95
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense						$ 0
Granted (in shares)			100,000
Granted (in dollars per share)			$ 18.08
Class A Common Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, offering date, percent of market price				85%
Purchase price of common stock, purchase date, percent of market price				85%
Class A Common Stock | Early Exercised Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Repurchase of unvested early exercised stock options (in shares)						0	400,000
2021 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of shares automatically increase				10 years
Percentage of total number of shares				5%
2021 Plan | RSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period						3 years
2021 Plan | RSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period						4 years
2021 Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)						173,700,000
2015 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)					0
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)									0
2018 Plan | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award service period					4 years
Stock-based compensation expense		$ 233,000

Equity Incentive Plans and St_4

Equity Incentive Plans and Stock-Based Compensation - Option Activity Under Stock Plans (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Stock Options
Outstanding, beginning balance (in shares)	13,898
Granted (in shares)	2,995
Exercised (in shares)	(5,221)
Forfeited (in shares)	(592)
Expired (in shares)	0
Outstanding, ending balance (in shares)	11,080	13,898
Weighted-Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 3.32
Granted (in dollars per share)	0.10
Exercised (in dollars per share)	1.29
Forfeited (in dollars per share)	1.80
Expired (in dollars per share)	0
Outstanding, ending balance (in dollars per share)	$ 3.49	$ 3.32
Outstanding, Weighted-Average Remaining Contractual Life (years)	7 years 9 months 18 days	7 years 8 months 12 days
Outstanding, Aggregate Intrinsic Value	$ 216,010	$ 169,324
Vested and exercisable, Number of Stock Options (in shares)	4,990
Vested and exercisable, Weighted-Average Exercise Price (in dollars per share)	$ 4.59
Vested and exercisable, Weighted-Average Remaining Contractual Life (years)	6 years 7 months 6 days
Vested and exercisable, Aggregate Intrinsic Value	$ 91,793

Equity Incentive Plans and St_5

Equity Incentive Plans and Stock-Based Compensation - Fair Value Assumptions for Stock Options (Details) - Stock Options - Weighted Average	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	5 years 10 months 24 days	5 years 10 months 24 days	6 years 1 month 6 days
Expected volatility	65.20%	60.60%	57.20%
Risk-free interest rate	3.60%	3.50%	1.40%
Expected dividend yield	0%	0%	0%

Equity Incentive Plans and St_6

Equity Incentive Plans and Stock-Based Compensation - Restricted Stock Unit Activity (Details) - RSUs shares in Thousands	12 Months Ended
	Jan. 31, 2024 $ / shares shares
RSUs
Unvested, beginning balance (in shares) | shares	36,785
Granted (in shares) | shares	19,274
Vested (in shares) | shares	(17,556)
Forfeited (in shares) | shares	(7,231)
Unvested, ending balance (in shares) | shares	31,272
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) | $ / shares	$ 22.48
Granted (in dollars per share) | $ / shares	16.95
Vested (in dollars per share) | $ / shares	20.64
Forfeited (in dollars per share) | $ / shares	23.39
Unvested, ending balance (in dollars per share) | $ / shares	$ 19.89

Equity Incentive Plans and St_7

Equity Incentive Plans and Stock-Based Compensation - Fair Value Assumptions for ESPP Shares (Details) - ESPP - Weighted Average	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	6 months	6 months	7 months 6 days
Expected volatility	67.40%	69%	55.70%
Risk-free interest rate	5.02%	1.86%	0.05%
Expected dividend yield	0%	0%	0%

Equity Incentive Plans and St_8

Equity Incentive Plans and Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 371,955	$ 369,840	$ 515,583
Capitalized stock-based compensation expenses relating to software development cost			4,500
Cost of revenue | Subscription services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	14,750	11,894	12,232
Cost of revenue | Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	10,958	11,855	29,849
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	144,863	154,922	237,975
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	117,965	102,546	135,713
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 83,419	$ 88,623	$ 99,814

Income Taxes - Domestic and For

Income Taxes - Domestic and Foreign Components of Loss before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Income Tax Disclosure [Abstract]
U.S.	$ (168,587)	$ (273,467)	$ (306,814)
Foreign	92,772	(44,094)	(204,069)
Loss before income taxes	$ (75,815)	$ (317,561)	$ (510,883)

Income Taxes - Components of th

Income Taxes - Components of the Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Current expense (benefit)
Federal	$ (106)	$ 213	$ 0
State	(166)	493	80
Foreign	13,786	9,224	20,455
Total current expense	13,514	9,930	20,535
Deferred expense (benefit)
Federal	0	0	0
State	0	0	0
Foreign	554	861	(5,832)
Total deferred expense (benefit)	554	861	(5,832)
Provision for income taxes	$ 14,068	$ 10,791	$ 14,703

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Statutory Federal Income Tax Rate to Effective Income Tax Rate (Details)	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Federal statutory income tax rate	21%	21%	21%
Foreign taxes	(2.00%)	(2.20%)	(3.70%)
Non-deductible expenses	(17.90%)	(2.10%)	(2.70%)
Stock-based compensation	(4.60%)	(10.80%)	27.10%
Valuation allowance	(5.70%)	(12.30%)	(48.20%)
Research and development credits	18.90%	3.30%	3.80%
Cross border tax law	(27.40%)	0%	0%
Other, net	(0.90%)	(0.30%)	(0.20%)
Effective income tax rate	(18.60%)	(3.40%)	(2.90%)

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Deferred tax assets:
Net operating loss carryforwards	$ 344,067	$ 387,822
Accruals and reserves	15,823	15,072
Stock-based compensation	11,888	25,665
Deferred revenue	25,942	9,477
Research and development	103,263	67,103
Depreciation and amortization	587	587
Excessive borrowing	0	1,668
Lease liabilities	11,563	0
Other	5,602	7,406
Total deferred tax assets, gross	518,735	514,800
Less: valuation allowance	(470,040)	(476,589)
Total deferred tax assets, net of valuation allowance	48,695	38,211
Deferred tax liabilities:
Intangible assets	(2,409)	(3,312)
Foreign exchange	(37)	(97)
Right-of-use assets	(8,957)	0
Commissions	(32,747)	(29,245)
Total deferred tax liabilities	(44,150)	(32,654)
Net deferred tax assets	4,545	5,557
Net deferred tax assets	4,678	5,895
Net deferred tax liabilities (included in other liabilities, non-current)	$ (133)	$ (338)

Income Taxes - Activity of the

Income Taxes - Activity of the Deferred Tax Asset Valuation Allowance (Details) - Valuation Allowance, Deferred Tax Asset - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning Balance	$ 476,589	$ 422,262
Additions During the Period	5,474	54,327
Reductions During the Period	(12,023)	0
Ending Balance	$ 470,040	$ 476,589

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	Jan. 31, 2024	Jan. 31, 2023	Jul. 09, 2020	Apr. 24, 2017
Operating Loss Carryforwards [Line Items]
Undistributed earnings of foreign subsidiaries	$ 109.2
Unrecognized tax benefits which would impact the effective tax rate if recognized	2.3
Unrecognized tax benefits	0.5	$ 2.3
Uncertain tax positions liability excluding interest and penalties		0.5
Federal
Operating Loss Carryforwards [Line Items]
Net operating losses	827.4	979.9
Net operating losses, annual limitation			$ 29	$ 0.1
State
Operating Loss Carryforwards [Line Items]
Net operating losses	824.7	771.5
Foreign | Romania
Operating Loss Carryforwards [Line Items]
Net operating losses	549.9	601.6
Foreign | Japan
Operating Loss Carryforwards [Line Items]
Net operating losses	6.3	10.4
Foreign | U.K.
Operating Loss Carryforwards [Line Items]
Net operating losses	$ 118.3	$ 135.1

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (89,883)	$ (328,352)	$ (525,586)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	563,855	548,022	454,625
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.16)	$ (0.60)	$ (1.16)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	563,855	548,022	454,625
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.16)	$ (0.60)	$ (1.16)
Class A Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (76,739)	$ (278,950)	$ (423,296)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	481,402	465,569	366,146
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.16)	$ (0.60)	$ (1.16)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	481,402	465,569	366,146
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.16)	$ (0.60)	$ (1.16)
Class B Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (13,144)	$ (49,402)	$ (102,290)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	82,453	82,453	88,479
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.16)	$ (0.60)	$ (1.16)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	82,453	82,453	88,479
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.16)	$ (0.60)	$ (1.16)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Class A Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	51,231	46,725	111,527
Class A Common Stock | Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	0	0	68,015
Class A Common Stock | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	36,878	31,427	23,237
Class A Common Stock | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	13,247	13,967	18,424
Class A Common Stock | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	52	284	1,539
Class A Common Stock | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	705	828	312
Class A Common Stock | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	349	219	0
Class B Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	0	0	0
Class B Common Stock | Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	0	0	0
Class B Common Stock | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	0	0	0
Class B Common Stock | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	0	0	0
Class B Common Stock | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	0	0	0
Class B Common Stock | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	0	0	0
Class B Common Stock | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive common stock equivalents (in shares)	0	0	0

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Related Party Transaction [Line Items]
Operating expenses	$ 1,276,868	$ 1,226,813	$ 1,224,330
Related Party
Related Party Transaction [Line Items]
Operating expenses	$ 0	$ 1,900	$ 1,100